ENTRY       hsa04144                    Pathway
NAME        Endocytosis - Homo sapiens (human)
DESCRIPTION Endocytosis is a mechanism for cells to remove ligands, nutrients, and plasma membrane (PM) proteins, and lipids from the cell surface, bringing them into the cell interior. Transmembrane proteins entering through clathrin-dependent endocytosis (CDE) have sequences in their cytoplasmic domains that bind to the APs (adaptor-related protein complexes) and enable their rapid removal from the PM. In addition to APs and clathrin, there are numerous accessory proteins including dynamin. Depending on the various proteins that enter the endosome membrane, these cargoes are sorted to distinct destinations. Some cargoes, such as nutrient receptors, are recycled back to the PM. Ubiquitylated membrane proteins, such as activated growth-factor receptors, are sorted into intraluminal vesicles and eventually end up in the lysosome lumen via multivesicular endosomes (MVEs). There are distinct mechanisms of clathrin-independent endocytosis (CIE) depending upon the cargo and the cell type.
CLASS       Cellular Processes; Transport and catabolism
PATHWAY_MAP hsa04144  Endocytosis
MODULE      hsa_M00408  ESCRT-0 complex [PATH:hsa04144]
            hsa_M00409  ESCRT-I complex [PATH:hsa04144]
            hsa_M00410  ESCRT-II complex [PATH:hsa04144]
            hsa_M00412  ESCRT-III complex [PATH:hsa04144]
DISEASE     H00078  Frontotemporal lobar degeneration (FTLD)
            H00155  Hypercholesterolemia
            H00265  Hereditary sensory and autonomic neuropathy (HSAN)
            H00567  Caveolinopathies
            H00593  Limb-girdle muscular dystrophy (LGMD)
            H00642  Lacrimo-auriculo-dento-digital syndrome (LADD)
            H00700  Centronuclear myopathy
            H00800  Loeys-Dietz syndrome (LDS)
            H00865  Lethal congenital contractural syndrome (LCCS)
            H01202  Cataract
            H01232  Syndromic multisystem autoimmune disease
            H01295  Neurodegeneration due to cerebral folate transport deficiency
            H01383  LDL Receptor Disorder
DRUG        D00095  Adrenaline (JP17)
            D00598  Betaxolol hydrochloride (JP17/USP)
            D00599  Carteolol hydrochloride (JP17/USP)
            D00603  Timolol maleate (JP17/USP)
            D00684  Bitolterol mesilate (JAN)
            D00685  Orciprenaline sulfate (JP17)
            D00686  Pirbuterol acetate (USAN)
            D00687  Salmeterol xinafoate (JAN/USAN)
            D00688  Terbutaline sulfate (JP17/USP)
            D01025  Levobunolol hydrochloride (JAN/USP)
            D01349  Pirbuterol hydrochloride (JAN/USAN)
            D01360  Clenbuterol hydrochloride (JAN/USP)
            D01362  Tulobuterol hydrochloride (JP17)
            D01373  Formoterol fumarate (USAN)
            D01428  Fenoterol hydrobromide (JAN)
            D01589  Mabuterol hydrochloride (JAN)
            D01635  Methoxyphenamine hydrochloride (JAN)
            D01691  Nipradilol (JAN/INN)
            D01748  Isoxsuprine hydrochloride (JP17/USP)
            D01835  Clorprenaline hydrochloride (JAN/USAN)
            D01978  Trimetoquinol hydrochloride
            D02093  Isoetharine hydrochloride (USP)
            D02147  Albuterol (USP)
            D02151  Tulobuterol (JP17/INN)
            D02281  Levalbuterol hydrochloride (USAN)
            D02396  Hexoprenaline sulfate (USAN)
            D02404  Procaterol hydrochloride (USAN)
            D02981  Arformoterol tartrate (USAN)
            D03058  Basiliximab (genetical recombination) (JAN)
            D03198  Butoxamine hydrochloride (USAN)
            D03210  Ancriviroc (USAN/INN)
            D03297  Mecasermin (genetical recombination) (JAN)
            D03402  Carbuterol hydrochloride (USAN)
            D03587  Colterol mesylate (USAN)
            D03639  Daclizumab (USAN/INN)
            D03682  Denileukin diftitox (USAN/INN)
            D03891  Dopexamine (USAN/INN)
            D04157  Fenoterol (USAN/INN)
            D04625  Isoetharine (USP)
            D04626  Isoetharine mesylate (USP)
            D04701  Levalbuterol sulfate (USAN)
            D04703  Levalbuterol tartrate (USAN)
            D04710  Levobetaxolol hydrochloride (USAN)
            D04870  Mecasermin rinfabate (USAN/INN)
            D04954  Metaproterenol polistirex (USAN)
            D05037  Trimetoquinol hydrochloride hydrate (JP17)
            D05277  Formoterol fumarate hydrate (JP17)
            D05366  Procaterol hydrochloride hydrate (JP17)
            D05476  Picumeterol fumarate (USAN)
            D05691  Ractopamine hydrochloride (USAN)
            D05718  Reproterol hydrochloride (USAN)
            D05730  Rimiterol hydrobromide (USAN)
            D05792  Salmeterol (USAN/INN)
            D05832  Sibenadet hydrochloride (USAN)
            D05879  Solabegron hydrochloride (USAN)
            D05902  Soterenol hydrochloride (USAN)
            D06297  Vicriviroc maleate (USAN)
            D06374  Zinterol hydrochloride (USAN)
            D06557  Aplaviroc hydrochloride (USAN)
            D06670  Maraviroc (JAN/INN)
            D07377  Bambuterol (INN)
            D07463  Arformoterol (INN)
            D07489  Bambuterol hydrochloride
            D07526  Betaxolol (INN)
            D07534  Bitolterol (INN)
            D07608  Carazolol (INN)
            D07624  Carteolol (INN)
            D07713  Clenbuterol (INN)
            D07990  Formoterol (INN)
            D08039  Hexoprenaline (INN)
            D08092  Isoxsuprine (INN)
            D08093  Isoxsuprine lactate
            D08115  Levobunolol (INN)
            D08124  Levosalbutamol (INN)
            D08300  Orciprenaline (INN)
            D08387  Pirbuterol (INN)
            D08424  Procaterol (INN)
            D08474  Reproterol (INN)
            D08570  Terbutaline (INN)
            D08629  Tretoquinol (INN)
            D09318  Indacaterol (USAN/INN)
            D09319  Indacaterol maleate (JAN/USAN)
            D09535  Mirabegron (USAN/JAN)
            D09732  Ritobegron ethyl hydrochloride (JAN)
            D09926  Icrucumab (USAN/INN)
            D10434  Vintafolide (USAN/INN)
            D10465  Golvatinib tartrate (USAN)
DBLINKS     BSID: 102279
            GO: 0006897
ORGANISM    Homo sapiens (human) [GN:hsa]
GENE        7040  TGFB1; transforming growth factor beta 1 [KO:K13375]
            7042  TGFB2; transforming growth factor beta 2 [KO:K13376]
            7043  TGFB3; transforming growth factor beta 3 [KO:K13377]
            7046  TGFBR1; transforming growth factor beta receptor I [KO:K04674] [EC:2.7.11.30]
            7048  TGFBR2; transforming growth factor beta receptor II [KO:K04388] [EC:2.7.11.30]
            9372  ZFYVE9; zinc finger FYVE-type containing 9 [KO:K04679]
            9765  ZFYVE16; zinc finger FYVE-type containing 16 [KO:K04679]
            5371  PML; promyelocytic leukemia [KO:K10054]
            4087  SMAD2; SMAD family member 2 [KO:K04500]
            4088  SMAD3; SMAD family member 3 [KO:K04500]
            7037  TFRC; transferrin receptor [KO:K06503]
            1956  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]
            2321  FLT1; fms related tyrosine kinase 1 [KO:K05096] [EC:2.7.10.1]
            3791  KDR; kinase insert domain receptor [KO:K05098] [EC:2.7.10.1]
            5156  PDGFRA; platelet derived growth factor receptor alpha [KO:K04363] [EC:2.7.10.1]
            2263  FGFR2; fibroblast growth factor receptor 2 [KO:K05093] [EC:2.7.10.1]
            2261  FGFR3; fibroblast growth factor receptor 3 [KO:K05094] [EC:2.7.10.1]
            2264  FGFR4; fibroblast growth factor receptor 4 [KO:K05095] [EC:2.7.10.1]
            3480  IGF1R; insulin like growth factor 1 receptor [KO:K05087] [EC:2.7.10.1]
            4233  MET; MET proto-oncogene, receptor tyrosine kinase [KO:K05099] [EC:2.7.10.1]
            4914  NTRK1; neurotrophic tyrosine kinase, receptor, type 1 [KO:K03176] [EC:2.7.10.1]
            2065  ERBB3; erb-b2 receptor tyrosine kinase 3 [KO:K05084] [EC:2.7.10.1]
            2066  ERBB4; erb-b2 receptor tyrosine kinase 4 [KO:K05085] [EC:2.7.10.1]
            3815  KIT; KIT proto-oncogene receptor tyrosine kinase [KO:K05091] [EC:2.7.10.1]
            5979  RET; ret proto-oncogene [KO:K05126] [EC:2.7.10.1]
            1436  CSF1R; colony stimulating factor 1 receptor [KO:K05090] [EC:2.7.10.1]
            1950  EGF; epidermal growth factor [KO:K04357]
            1759  DNM1; dynamin 1 [KO:K01528] [EC:3.6.5.5]
            1785  DNM2; dynamin 2 [KO:K01528] [EC:3.6.5.5]
            26052  DNM3; dynamin 3 [KO:K01528] [EC:3.6.5.5]
            382  ARF6; ADP ribosylation factor 6 [KO:K07941]
            23396  PIP5K1C; phosphatidylinositol-4-phosphate 5-kinase, type I, gamma [KO:K00889] [EC:2.7.1.68]
            8394  PIP5K1A; phosphatidylinositol-4-phosphate 5-kinase, type I, alpha [KO:K00889] [EC:2.7.1.68]
            8395  PIP5K1B; phosphatidylinositol-4-phosphate 5-kinase, type I, beta [KO:K00889] [EC:2.7.1.68]
            138429  PIP5KL1; phosphatidylinositol-4-phosphate 5-kinase-like 1 [KO:K13712] [EC:2.7.1.68]
            5337  PLD1; phospholipase D1 [KO:K01115] [EC:3.1.4.4]
            5338  PLD2; phospholipase D2 [KO:K01115] [EC:3.1.4.4]
            1211  CLTA; clathrin light chain A [KO:K04644]
            1212  CLTB; clathrin light chain B [KO:K04645]
            1213  CLTC; clathrin heavy chain [KO:K04646]
            8218  CLTCL1; clathrin heavy chain like 1 [KO:K04646]
            161  AP2A2; adaptor related protein complex 2 alpha 2 subunit [KO:K11824]
            160  AP2A1; adaptor related protein complex 2 alpha 1 subunit [KO:K11824]
            163  AP2B1; adaptor related protein complex 2 beta 1 subunit [KO:K11825]
            1173  AP2M1; adaptor related protein complex 2 mu 1 subunit [KO:K11826]
            1175  AP2S1; adaptor related protein complex 2 sigma 1 subunit [KO:K11827]
            30846  EHD2; EH domain containing 2 [KO:K12469]
            23624  CBLC; Cbl proto-oncogene C, E3 ubiquitin protein ligase [KO:K04707] [EC:2.3.2.27]
            867  CBL; Cbl proto-oncogene, E3 ubiquitin protein ligase [KO:K04707] [EC:2.3.2.27]
            868  CBLB; Cbl proto-oncogene B, E3 ubiquitin protein ligase [KO:K04707] [EC:2.3.2.27]
            4734  NEDD4; neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase [KO:K10591] [EC:2.3.2.26]
            23327  NEDD4L; neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase [KO:K13305] [EC:2.3.2.26]
            4193  MDM2; MDM2 proto-oncogene [KO:K06643] [EC:2.3.2.27]
            7189  TRAF6; TNF receptor associated factor 6 [KO:K03175] [EC:2.3.2.27]
            10193  RNF41; ring finger protein 41 [KO:K11981] [EC:2.3.2.27]
            83737  ITCH; itchy E3 ubiquitin protein ligase [KO:K05632] [EC:2.3.2.26]
            57154  SMURF1; SMAD specific E3 ubiquitin protein ligase 1 [KO:K04678] [EC:2.3.2.26]
            64750  SMURF2; SMAD specific E3 ubiquitin protein ligase 2 [KO:K04678] [EC:2.3.2.26]
            11059  WWP1; WW domain containing E3 ubiquitin protein ligase 1 [KO:K05633] [EC:2.3.2.26]
            30011  SH3KBP1; SH3-domain kinase binding protein 1 [KO:K12470]
            6457  SH3GL3; SH3-domain GRB2-like 3 [KO:K11247]
            6456  SH3GL2; SH3-domain GRB2-like 2 [KO:K11247]
            6455  SH3GL1; SH3-domain GRB2-like 1 [KO:K11247]
            51100  SH3GLB1; SH3-domain GRB2 like endophilin B1 [KO:K11248]
            56904  SH3GLB2; SH3-domain GRB2-like endophilin B2 [KO:K11248]
            273  AMPH; amphiphysin [KO:K12562]
            274  BIN1; bridging integrator 1 [KO:K12562]
            29924  EPN1; epsin 1 [KO:K12471]
            55040  EPN3; epsin 3 [KO:K12471]
            22905  EPN2; epsin 2 [KO:K12471]
            2060  EPS15; epidermal growth factor receptor pathway substrate 15 [KO:K12472]
            58513  EPS15L1; epidermal growth factor receptor pathway substrate 15-like 1 [KO:K12472]
            23111  SPG20; spastic paraplegia 20 (Troyer syndrome) [KO:K19366]
            3949  LDLR; low density lipoprotein receptor [KO:K12473]
            26119  LDLRAP1; low density lipoprotein receptor adaptor protein 1 [KO:K12474]
            1601  DAB2; DAB2, clathrin adaptor protein [KO:K12475]
            1234  CCR5; C-C motif chemokine receptor 5 (gene/pseudogene) [KO:K04180]
            3577  CXCR1; C-X-C motif chemokine receptor 1 [KO:K04175]
            3579  CXCR2; C-X-C motif chemokine receptor 2 [KO:K05050]
            7852  CXCR4; C-X-C motif chemokine receptor 4 [KO:K04189]
            2149  F2R; coagulation factor II thrombin receptor [KO:K03914]
            153  ADRB1; adrenoceptor beta 1 [KO:K04141]
            154  ADRB2; adrenoceptor beta 2 [KO:K04142]
            155  ADRB3; adrenoceptor beta 3 [KO:K04143]
            131890  GRK7; G protein-coupled receptor kinase 7 [KO:K00909] [EC:2.7.11.14]
            6011  GRK1; G protein-coupled receptor kinase 1 [KO:K00909] [EC:2.7.11.14]
            156  ADRBK1; adrenergic, beta, receptor kinase 1 [KO:K00910] [EC:2.7.11.15]
            157  ADRBK2; adrenergic, beta, receptor kinase 2 [KO:K00910] [EC:2.7.11.15]
            2868  GRK4; G protein-coupled receptor kinase 4 [KO:K08291] [EC:2.7.11.16]
            2869  GRK5; G protein-coupled receptor kinase 5 [KO:K08291] [EC:2.7.11.16]
            2870  GRK6; G protein-coupled receptor kinase 6 [KO:K08291] [EC:2.7.11.16]
            408  ARRB1; arrestin, beta 1 [KO:K04439]
            409  ARRB2; arrestin, beta 2 [KO:K04439]
            7454  WAS; Wiskott-Aldrich syndrome [KO:K05747]
            8976  WASL; Wiskott-Aldrich syndrome like [KO:K05747]
            10095  ARPC1B; actin related protein 2/3 complex subunit 1B [KO:K05757]
            10552  ARPC1A; actin related protein 2/3 complex subunit 1A [KO:K05757]
            10109  ARPC2; actin related protein 2/3 complex subunit 2 [KO:K05758]
            10094  ARPC3; actin related protein 2/3 complex subunit 3 [KO:K05756]
            10093  ARPC4; actin related protein 2/3 complex subunit 4 [KO:K05755]
            10092  ARPC5; actin related protein 2/3 complex subunit 5 [KO:K05754]
            81873  ARPC5L; actin related protein 2/3 complex subunit 5-like [KO:K05754]
            147179  WIPF2; WAS/WASL interacting protein family member 2 [KO:K19475]
            7456  WIPF1; WAS/WASL interacting protein family member 1 [KO:K19475]
            644150  WIPF3; WAS/WASL interacting protein family member 3 [KO:K19475]
            3312  HSPA8; heat shock protein family A (Hsp70) member 8 [KO:K03283]
            3303  HSPA1A; heat shock protein family A (Hsp70) member 1A [KO:K03283]
            3306  HSPA2; heat shock protein family A (Hsp70) member 2 [KO:K03283]
            3305  HSPA1L; heat shock protein family A (Hsp70) member 1 like [KO:K03283]
            3304  HSPA1B; heat shock protein family A (Hsp70) member 1B [KO:K03283]
            3310  HSPA6; heat shock protein family A (Hsp70) member 6 [KO:K03283]
            9829  DNAJC6; DnaJ heat shock protein family (Hsp40) member C6 [KO:K09526]
            23325  MRT43; KIAA1033 [KO:K18465]
            9897  RTSC; KIAA0196 [KO:K18464]
            253725  FAM21C; family with sequence similarity 21 member C [KO:K18462]
            387680  FAM21A; family with sequence similarity 21 member A [KO:K18462]
            100287171  WASH1; WAS protein family homolog 1 [KO:K18461]
            51019  CCDC53; coiled-coil domain containing 53 [KO:K18463]
            829  CAPZA1; capping actin protein of muscle Z-line alpha subunit 1 [KO:K10364]
            830  CAPZA2; capping actin protein of muscle Z-line alpha subunit 2 [KO:K10364]
            93661  CAPZA3; capping actin protein of muscle Z-line alpha subunit 3 [KO:K10364]
            832  CAPZB; capping actin protein of muscle Z-line beta subunit [KO:K10365]
            51699  VPS29; VPS29, retromer complex component [KO:K18467]
            112936  VPS26B; VPS26 retromer complex component B [KO:K18466]
            9559  VPS26A; VPS26 retromer complex component A [KO:K18466]
            55737  VPS35; VPS35, retromer complex component [KO:K18468]
            29934  SNX12; sorting nexin 12 [KO:K17918]
            8724  SNX3; sorting nexin 3 [KO:K17918]
            9101  USP8; ubiquitin specific peptidase 8 [KO:K11839] [EC:3.4.19.12]
            10617  STAMBP; STAM binding protein [KO:K11866] [EC:3.4.19.12]
            7879  RAB7A; RAB7A, member RAS oncogene family [KO:K07897]
            9146  HGS; hepatocyte growth factor-regulated tyrosine kinase substrate [KO:K12182]
            10254  STAM2; signal transducing adaptor molecule 2 [KO:K04705]
            8027  STAM; signal transducing adaptor molecule [KO:K04705]
            7251  TSG101; tumor susceptibility 101 [KO:K12183]
            93343  MVB12A; multivesicular body subunit 12A [KO:K12186]
            89853  MVB12B; multivesicular body subunit 12B [KO:K12186]
            51160  VPS28; VPS28, ESCRT-I subunit [KO:K12184]
            155382  VPS37D; VPS37D, ESCRT-I subunit [KO:K12185]
            137492  VPS37A; VPS37A, ESCRT-I subunit [KO:K12185]
            79720  VPS37B; VPS37B, ESCRT-I subunit [KO:K12185]
            55048  VPS37C; VPS37C, ESCRT-I subunit [KO:K12185]
            11267  SNF8; SNF8, ESCRT-II complex subunit [KO:K12188]
            51028  VPS36; vacuolar protein sorting 36 homolog (S. cerevisiae) [KO:K12190]
            84313  VPS25; vacuolar protein sorting 25 homolog (S. cerevisiae) [KO:K12189]
            79643  CHMP6; charged multivesicular body protein 6 [KO:K12195]
            92421  CHMP4C; charged multivesicular body protein 4C [KO:K12194]
            128866  CHMP4B; charged multivesicular body protein 4B [KO:K12194]
            29082  CHMP4A; charged multivesicular body protein 4A [KO:K12194]
            51652  CHMP3; charged multivesicular body protein 3 [KO:K12193]
            100526767  RNF103-CHMP3; RNF103-CHMP3 readthrough [KO:K12193]
            27243  CHMP2A; charged multivesicular body protein 2A [KO:K12191]
            25978  CHMP2B; charged multivesicular body protein 2B [KO:K12192]
            91782  CHMP7; charged multivesicular body protein 7 [KO:K15053]
            9525  VPS4B; vacuolar protein sorting 4 homolog B (S. cerevisiae) [KO:K12196]
            27183  VPS4A; vacuolar protein sorting 4 homolog A (S. cerevisiae) [KO:K12196]
            51534  VTA1; vesicle (multivesicular body) trafficking 1 [KO:K12199]
            57132  CHMP1B; charged multivesicular body protein 1B [KO:K12197]
            51510  CHMP5; charged multivesicular body protein 5 [KO:K12198]
            9798  IST1; IST1, ESCRT-III associated factor [KO:K19476]
            10015  PDCD6IP; programmed cell death 6 interacting protein [KO:K12200]
            51324  SPG21; spastic paraplegia 21 (autosomal recessive, Mast syndrome) [KO:K19367]
            3482  IGF2R; insulin like growth factor 2 receptor [KO:K06564]
            6642  SNX1; sorting nexin 1 [KO:K17917]
            6643  SNX2; sorting nexin 2 [KO:K17917]
            254122  SNX32; sorting nexin 32 [KO:K17920]
            27131  SNX5; sorting nexin 5 [KO:K17920]
            58533  SNX6; sorting nexin 6 [KO:K17920]
            6714  SRC; SRC proto-oncogene, non-receptor tyrosine kinase [KO:K05704] [EC:2.7.10.2]
            3265  HRAS; Harvey rat sarcoma viral oncogene homolog [KO:K02833]
            3559  IL2RA; interleukin 2 receptor subunit alpha [KO:K05068]
            3560  IL2RB; interleukin 2 receptor subunit beta [KO:K05069]
            3561  IL2RG; interleukin 2 receptor subunit gamma [KO:K05070]
            387  RHOA; ras homolog family member A [KO:K04513]
            3105  HLA-A; major histocompatibility complex, class I, A [KO:K06751]
            3106  HLA-B; major histocompatibility complex, class I, B [KO:K06751]
            3107  HLA-C; major histocompatibility complex, class I, C [KO:K06751]
            3134  HLA-F; major histocompatibility complex, class I, F [KO:K06751]
            3135  HLA-G; major histocompatibility complex, class I, G [KO:K06751]
            3133  HLA-E; major histocompatibility complex, class I, E [KO:K06751]
            2348  FOLR1; folate receptor 1 (adult) [KO:K13649]
            2350  FOLR2; folate receptor 2 (fetal) [KO:K13649]
            2352  FOLR3; folate receptor 3 (gamma) [KO:K13649]
            390243  IZUMO1R; IZUMO1 receptor, JUNO [KO:K13649]
            857  CAV1; caveolin 1 [KO:K06278]
            858  CAV2; caveolin 2 [KO:K12958]
            859  CAV3; caveolin 3 [KO:K12959]
            30845  EHD3; EH domain containing 3 [KO:K12476]
            30844  EHD4; EH domain containing 4 [KO:K12477]
            8411  EEA1; early endosome antigen 1 [KO:K12478]
            5868  RAB5A; RAB5A, member RAS oncogene family [KO:K07887]
            5869  RAB5B; RAB5B, member RAS oncogene family [KO:K07888]
            5878  RAB5C; RAB5C, member RAS oncogene family [KO:K07889]
            9135  RABEP1; rabaptin, RAB GTPase binding effector protein 1 [KO:K12480]
            64145  RBSN; rabenosyn, RAB effector [KO:K12481]
            5867  RAB4A; RAB4A, member RAS oncogene family [KO:K07879]
            80230  RUFY1; RUN and FYVE domain containing 1 [KO:K12482]
            10938  EHD1; EH domain containing 1 [KO:K12483]
            11311  VPS45; vacuolar protein sorting 45 homolog (S. cerevisiae) [KO:K12479]
            8723  SNX4; sorting nexin 4 [KO:K17919]
            57403  RAB22A; RAB22A, member RAS oncogene family [KO:K07891]
            11031  RAB31; RAB31, member RAS oncogene family [KO:K07891]
            10890  RAB10; RAB10, member RAS oncogene family [KO:K07903]
            4218  RAB8A; RAB8A, member RAS oncogene family [KO:K07901]
            11021  RAB35; RAB35, member RAS oncogene family [KO:K07876]
            8766  RAB11A; RAB11A, member RAS oncogene family [KO:K07904]
            9230  RAB11B; RAB11B, member RAS oncogene family [KO:K07905]
            22841  RAB11FIP2; RAB11 family interacting protein 2 (class I) [KO:K12484]
            80223  RAB11FIP1; RAB11 family interacting protein 1 (class I) [KO:K12484]
            26056  RAB11FIP5; RAB11 family interacting protein 5 (class I) [KO:K12484]
            118813  ZFYVE27; zinc finger FYVE-type containing 27 [KO:K19368]
            3798  KIF5A; kinesin family member 5A [KO:K10396]
            3799  KIF5B; kinesin family member 5B [KO:K10396]
            3800  KIF5C; kinesin family member 5C [KO:K10396]
            84440  RAB11FIP4; RAB11 family interacting protein 4 (class II) [KO:K12485]
            9727  RAB11FIP3; RAB11 family interacting protein 3 (class II) [KO:K12485]
            56288  PARD3; par-3 family cell polarity regulator [KO:K04237]
            50855  PARD6A; par-6 family cell polarity regulator alpha [KO:K06093]
            84552  PARD6G; par-6 family cell polarity regulator gamma [KO:K06093]
            84612  PARD6B; par-6 family cell polarity regulator beta [KO:K06093]
            5590  PRKCZ; protein kinase C zeta [KO:K18952] [EC:2.7.11.13]
            5584  PRKCI; protein kinase C iota [KO:K06069] [EC:2.7.11.13]
            998  CDC42; cell division cycle 42 [KO:K04393]
            64744  SMAP2; small ArfGAP2 [KO:K12486]
            60682  SMAP1; small ArfGAP 1 [KO:K12486]
            28964  GIT1; GIT ArfGAP 1 [KO:K05737]
            9815  GIT2; GIT ArfGAP 2 [KO:K12487]
            50807  ASAP1; ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 [KO:K12488]
            55616  ASAP3; ArfGAP with SH3 domain, ankyrin repeat and PH domain 3 [KO:K12488]
            8853  ASAP2; ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 [KO:K12488]
            116983  ACAP3; ArfGAP with coiled-coil, ankyrin repeat and PH domains 3 [KO:K12489]
            23527  ACAP2; ArfGAP with coiled-coil, ankyrin repeat and PH domains 2 [KO:K12489]
            9744  ACAP1; ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 [KO:K12489]
            116985  ARAP1; ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 [KO:K18439]
            116984  ARAP2; ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2 [KO:K18440]
            64411  ARAP3; ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3 [KO:K12490]
            116987  AGAP1; ArfGAP with GTPase domain, ankyrin repeat and PH domain 1 [KO:K12491]
            116988  AGAP3; ArfGAP with GTPase domain, ankyrin repeat and PH domain 3 [KO:K12491]
            116986  AGAP2; ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 [KO:K17848]
            55738  ARFGAP1; ADP ribosylation factor GTPase activating protein 1 [KO:K12492]
            26286  ARFGAP3; ADP ribosylation factor GTPase activating protein 3 [KO:K12493]
            84364  ARFGAP2; ADP ribosylation factor GTPase activating protein 2 [KO:K12493]
            23362  PSD3; pleckstrin and Sec7 domain containing 3 [KO:K12494]
            23550  PSD4; pleckstrin and Sec7 domain containing 4 [KO:K12494]
            5662  PSD; pleckstrin and Sec7 domain containing [KO:K12494]
            84249  PSD2; pleckstrin and Sec7 domain containing 2 [KO:K12494]
            23096  IQSEC2; IQ motif and Sec7 domain 2 [KO:K12495]
            9922  IQSEC1; IQ motif and Sec7 domain 1 [KO:K12495]
            440073  IQSEC3; IQ motif and Sec7 domain 3 [KO:K12495]
            9265  CYTH3; cytohesin 3 [KO:K18441]
            27128  CYTH4; cytohesin 4 [KO:K18441]
            9266  CYTH2; cytohesin 2 [KO:K18441]
            9267  CYTH1; cytohesin 1 [KO:K18441]
            10564  ARFGEF2; ADP ribosylation factor guanine nucleotide exchange factor 2 [KO:K18442]
            10565  ARFGEF1; ADP ribosylation factor guanine nucleotide exchange factor 1 [KO:K18442]
            8729  GBF1; golgi brefeldin A resistant guanine nucleotide exchange factor 1 [KO:K18443]
            375  ARF1; ADP ribosylation factor 1 [KO:K07937]
            377  ARF3; ADP ribosylation factor 3 [KO:K07938]
            381  ARF5; ADP ribosylation factor 5 [KO:K07940]
COMPOUND    C00035  GDP
            C00044  GTP
            C04549  1-Phosphatidyl-1D-myo-inositol 3-phosphate
            C04637  1-Phosphatidyl-D-myo-inositol 4,5-bisphosphate
            C05981  Phosphatidylinositol-3,4,5-trisphosphate
            C11556  1-Phosphatidyl-1D-myo-inositol 3,5-bisphosphate
REFERENCE   PMID:19007773
  AUTHORS   Acconcia F, Sigismund S, Polo S
  TITLE     Ubiquitin in trafficking: the network at work.
  JOURNAL   Exp Cell Res 315:1610-8 (2009)
REFERENCE   PMID:18647649
  AUTHORS   Donaldson JG, Porat-Shliom N, Cohen LA
  TITLE     Clathrin-independent endocytosis: a unique platform for cell signaling and PM remodeling.
  JOURNAL   Cell Signal 21:1-6 (2009)
REFERENCE   PMID:15261671
  AUTHORS   Sorkin A
  TITLE     Cargo recognition during clathrin-mediated endocytosis: a team effort.
  JOURNAL   Curr Opin Cell Biol 16:392-9 (2004)
REFERENCE   PMID:19325624
  AUTHORS   Raiborg C, Stenmark H
  TITLE     The ESCRT machinery in endosomal sorting of ubiquitylated membrane proteins.
  JOURNAL   Nature 458:445-52 (2009)
REFERENCE   (Japanese)
  AUTHORS   Ohno H, Yoshimori T (eds).
  TITLE     [Current Stream in Membrane Traffic] (in Japanese)
  JOURNAL   Tanpakushitsu Kakusan Koso 53 (2008)
REFERENCE   PMID:20110990
  AUTHORS   Scita G, Di Fiore PP
  TITLE     The endocytic matrix.
  JOURNAL   Nature 463:464-73 (2010)
REFERENCE   PMID:15687999
  AUTHORS   Le Roy C, Wrana JL
  TITLE     Clathrin- and non-clathrin-mediated endocytic regulation of cell signalling.
  JOURNAL   Nat Rev Mol Cell Biol 6:112-26 (2005)
REFERENCE   PMID:19924646
  AUTHORS   Jovic M, Sharma M, Rahajeng J, Caplan S
  TITLE     The early endosome: a busy sorting station for proteins at the crossroads.
  JOURNAL   Histol Histopathol 25:99-112 (2010)
REFERENCE   PMID:16203612
  AUTHORS   Pietiainen VM, Marjomaki V, Heino J, Hyypia T
  TITLE     Viral entry, lipid rafts and caveosomes.
  JOURNAL   Ann Med 37:394-403 (2005)
REFERENCE   PMID:19696797
  AUTHORS   Grant BD, Donaldson JG
  TITLE     Pathways and mechanisms of endocytic recycling.
  JOURNAL   Nat Rev Mol Cell Biol 10:597-608 (2009)
REFERENCE   PMID:22193161
  AUTHORS   Cullen PJ, Korswagen HC
  TITLE     Sorting nexins provide diversity for retromer-dependent trafficking events.
  JOURNAL   Nat Cell Biol 14:29-37 (2012)
KO_PATHWAY  ko04144
///
ENTRY       hsa04145                    Pathway
NAME        Phagosome - Homo sapiens (human)
DESCRIPTION Phagocytosis is the process of taking in relatively large particles by a cell, and is a central mechanism in the tissue remodeling, inflammation, and defense against infectious agents. A phagosome is formed when the specific receptors on the phagocyte surface recognize ligands on the particle surface. After formation, nascent phagosomes progressively acquire digestive characteristics. This maturation of phagosomes involves regulated interaction with the other membrane organelles, including recycling endosomes, late endosomes and lysosomes. The fusion of phagosomes and lysosomes releases toxic products that kill most bacteria and degrade them into fragments. However, some bacteria have strategies to escape the bactericidal mechanisms associated with phagocytosis and survive within host phagocytes.
CLASS       Cellular Processes; Transport and catabolism
PATHWAY_MAP hsa04145  Phagosome
MODULE      hsa_M00401  Sec61 complex [PATH:hsa04145]
DISEASE     H00265  Hereditary sensory and autonomic neuropathy (HSAN)
            H00751  Asphyxiating thoracic dystrophy
            H00821  Macular degeneration
            H00838  Congenital fibrosis of the extraocular muscles (CFEOM)
            H00856  Distal hereditary motor neuropathies (dHMN)
            H00957  Fleck corneal dystrophy (FCD)
            H00984  Bare lymphocyte syndrome (BLS) type1
            H01108  CD36 deficiency
            H01109  Chronic mucocutaneous candidiasis (CMC)
            H01240  Immune thrombocytopenia (ITP)
            H01255  Juvenile-onset dystonia
DRUG        D10028  Valategrast hydrochloride (USAN)
DBLINKS     BSID: 153910
            GO: 0045335
ORGANISM    Homo sapiens (human) [GN:hsa]
GENE        9341  VAMP3; vesicle associated membrane protein 3 [KO:K13505]
            23673  STX12; syntaxin 12 [KO:K13813]
            8417  STX7; syntaxin 7 [KO:K08488]
            60  ACTB; actin, beta [KO:K05692]
            71  ACTG1; actin gamma 1 [KO:K05692]
            11151  CORO1A; coronin 1A [KO:K13882]
            53407  STX18; syntaxin 18 [KO:K08492]
            9554  SEC22B; SEC22 homolog B, vesicle trafficking protein (gene/pseudogene) [KO:K08517]
            3105  HLA-A; major histocompatibility complex, class I, A [KO:K06751]
            3106  HLA-B; major histocompatibility complex, class I, B [KO:K06751]
            3107  HLA-C; major histocompatibility complex, class I, C [KO:K06751]
            3134  HLA-F; major histocompatibility complex, class I, F [KO:K06751]
            3135  HLA-G; major histocompatibility complex, class I, G [KO:K06751]
            3133  HLA-E; major histocompatibility complex, class I, E [KO:K06751]
            3108  HLA-DMA; major histocompatibility complex, class II, DM alpha [KO:K06752]
            3109  HLA-DMB; major histocompatibility complex, class II, DM beta [KO:K06752]
            3111  HLA-DOA; major histocompatibility complex, class II, DO alpha [KO:K06752]
            3112  HLA-DOB; major histocompatibility complex, class II, DO beta [KO:K06752]
            3113  HLA-DPA1; major histocompatibility complex, class II, DP alpha 1 [KO:K06752]
            3115  HLA-DPB1; major histocompatibility complex, class II, DP beta 1 [KO:K06752]
            3117  HLA-DQA1; major histocompatibility complex, class II, DQ alpha 1 [KO:K06752]
            3118  HLA-DQA2; major histocompatibility complex, class II, DQ alpha 2 [KO:K06752]
            3119  HLA-DQB1; major histocompatibility complex, class II, DQ beta 1 [KO:K06752]
            3122  HLA-DRA; major histocompatibility complex, class II, DR alpha [KO:K06752]
            3123  HLA-DRB1; major histocompatibility complex, class II, DR beta 1 [KO:K06752]
            3125  HLA-DRB3; major histocompatibility complex, class II, DR beta 3 [KO:K06752]
            3126  HLA-DRB4; major histocompatibility complex, class II, DR beta 4 [KO:K06752]
            3127  HLA-DRB5; major histocompatibility complex, class II, DR beta 5 [KO:K06752]
            5868  RAB5A; RAB5A, member RAS oncogene family [KO:K07887]
            5869  RAB5B; RAB5B, member RAS oncogene family [KO:K07888]
            5878  RAB5C; RAB5C, member RAS oncogene family [KO:K07889]
            8411  EEA1; early endosome antigen 1 [KO:K12478]
            5289  PIK3C3; phosphatidylinositol 3-kinase catalytic subunit type 3 [KO:K00914] [EC:2.7.1.137]
            7037  TFRC; transferrin receptor [KO:K06503]
            9146  HGS; hepatocyte growth factor-regulated tyrosine kinase substrate [KO:K12182]
            523  ATP6V1A; ATPase H+ transporting V1 subunit A [KO:K02145] [EC:3.6.3.14]
            525  ATP6V1B1; ATPase H+ transporting V1 subunit B1 [KO:K02147]
            526  ATP6V1B2; ATPase H+ transporting V1 subunit B2 [KO:K02147]
            245973  ATP6V1C2; ATPase H+ transporting V1 subunit C2 [KO:K02148]
            528  ATP6V1C1; ATPase H+ transporting V1 subunit C1 [KO:K02148]
            51382  ATP6V1D; ATPase H+ transporting V1 subunit D [KO:K02149]
            90423  ATP6V1E2; ATPase H+ transporting V1 subunit E2 [KO:K02150]
            529  ATP6V1E1; ATPase H+ transporting V1 subunit E1 [KO:K02150]
            9296  ATP6V1F; ATPase H+ transporting V1 subunit F [KO:K02151]
            9550  ATP6V1G1; ATPase H+ transporting V1 subunit G1 [KO:K02152]
            127124  ATP6V1G3; ATPase H+ transporting V1 subunit G3 [KO:K02152]
            534  ATP6V1G2; ATPase H+ transporting V1 subunit G2 [KO:K02152]
            8992  ATP6V0E1; ATPase H+ transporting V0 subunit e1 [KO:K02153]
            155066  ATP6V0E2; ATPase H+ transporting V0 subunit e2 [KO:K02153]
            10312  TCIRG1; T-cell immune regulator 1, ATPase H+ transporting V0 subunit a3 [KO:K02154]
            23545  ATP6V0A2; ATPase H+ transporting V0 subunit a2 [KO:K02154]
            50617  ATP6V0A4; ATPase H+ transporting V0 subunit a4 [KO:K02154]
            535  ATP6V0A1; ATPase H+ transporting V0 subunit a1 [KO:K02154]
            9114  ATP6V0D1; ATPase H+ transporting V0 subunit d1 [KO:K02146]
            245972  ATP6V0D2; ATPase H+ transporting V0 subunit d2 [KO:K02146]
            51606  ATP6V1H; ATPase H+ transporting V1 subunit H [KO:K02144]
            527  ATP6V0C; ATPase H+ transporting V0 subunit c [KO:K02155]
            533  ATP6V0B; ATPase H+ transporting V0 subunit b [KO:K03661]
            537  ATP6AP1; ATPase H+ transporting accessory protein 1 [KO:K03662]
            7879  RAB7A; RAB7A, member RAS oncogene family [KO:K07897]
            338382  RAB7B; RAB7B, member RAS oncogene family [KO:K07898]
            83547  RILP; Rab interacting lysosomal protein [KO:K13883]
            1778  DYNC1H1; dynein cytoplasmic 1 heavy chain 1 [KO:K10413]
            79659  DYNC2H1; dynein cytoplasmic 2 heavy chain 1 [KO:K10414]
            1780  DYNC1I1; dynein cytoplasmic 1 intermediate chain 1 [KO:K10415]
            1781  DYNC1I2; dynein cytoplasmic 1 intermediate chain 2 [KO:K10415]
            1783  DYNC1LI2; dynein cytoplasmic 1 light intermediate chain 2 [KO:K10416]
            51143  DYNC1LI1; dynein cytoplasmic 1 light intermediate chain 1 [KO:K10416]
            10376  TUBA1B; tubulin alpha 1b [KO:K07374]
            7277  TUBA4A; tubulin alpha 4a [KO:K07374]
            7278  TUBA3C; tubulin alpha 3c [KO:K07374]
            7846  TUBA1A; tubulin alpha 1a [KO:K07374]
            84790  TUBA1C; tubulin alpha 1c [KO:K07374]
            51807  TUBA8; tubulin alpha 8 [KO:K07374]
            112714  TUBA3E; tubulin alpha 3e [KO:K07374]
            113457  TUBA3D; tubulin alpha 3d [KO:K07374]
            79861  TUBAL3; tubulin alpha like 3 [KO:K07374]
            84617  TUBB6; tubulin beta 6 class V [KO:K07375]
            203068  TUBB; tubulin beta class I [KO:K07375]
            81027  TUBB1; tubulin beta 1 class VI [KO:K07375]
            7280  TUBB2A; tubulin beta 2A class IIa [KO:K07375]
            10381  TUBB3; tubulin beta 3 class III [KO:K07375]
            10382  TUBB4A; tubulin beta 4A class IVa [KO:K07375]
            347688  TUBB8; tubulin beta 8 class VIII [KO:K07375]
            347733  TUBB2B; tubulin beta 2B class IIb [KO:K07375]
            10383  TUBB4B; tubulin beta 4B class IVb [KO:K07375]
            3916  LAMP1; lysosomal associated membrane protein 1 [KO:K06528]
            3920  LAMP2; lysosomal associated membrane protein 2 [KO:K06528]
            200576  PIKFYVE; phosphoinositide kinase, FYVE-type zinc finger containing [KO:K00921] [EC:2.7.1.150]
            4074  M6PR; mannose-6-phosphate receptor, cation dependent [KO:K10089]
            4842  NOS1; nitric oxide synthase 1 [KO:K13240] [EC:1.14.13.39]
            4353  MPO; myeloperoxidase [KO:K10789] [EC:1.11.2.2]
            1514  CTSL; cathepsin L [KO:K01365] [EC:3.4.22.15]
            1520  CTSS; cathepsin S [KO:K01368] [EC:3.4.22.27]
            29927  SEC61A1; Sec61 translocon alpha 1 subunit [KO:K10956]
            55176  SEC61A2; Sec61 translocon alpha 2 subunit [KO:K10956]
            10952  SEC61B; Sec61 translocon beta subunit [KO:K09481]
            23480  SEC61G; Sec61 translocon gamma subunit [KO:K07342]
            6890  TAP1; transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) [KO:K05653]
            6891  TAP2; transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) [KO:K05654]
            811  CALR; calreticulin [KO:K08057]
            821  CANX; calnexin [KO:K08054]
            2204  FCAR; Fc fragment of IgA receptor [KO:K06513]
            2209  FCGR1A; Fc fragment of IgG receptor Ia [KO:K06498]
            2212  FCGR2A; Fc fragment of IgG receptor IIa [KO:K06472]
            2213  FCGR2B; Fc fragment of IgG receptor IIb [KO:K12560]
            9103  FCGR2C; Fc fragment of IgG receptor IIc (gene/pseudogene) [KO:K16824]
            2214  FCGR3A; Fc fragment of IgG receptor IIIa [KO:K06463]
            2215  FCGR3B; Fc fragment of IgG receptor IIIb [KO:K06463]
            102723407  putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8; K06856 immunoglobulin heavy chain [KO:K06856]
            715  C1R; complement C1r subcomponent [KO:K01330] [EC:3.4.21.41]
            3684  ITGAM; integrin subunit alpha M [KO:K06461]
            3689  ITGB2; integrin subunit beta 2 [KO:K06464]
            718  C3; complement component 3 [KO:K03990]
            78989  COLEC11; collectin subfamily member 11 [KO:K10066]
            81035  COLEC12; collectin subfamily member 12 [KO:K10062]
            4153  MBL2; mannose binding lectin 2 [KO:K03991]
            653509  SFTPA1; surfactant protein A1 [KO:K10067]
            729238  SFTPA2; surfactant protein A2 [KO:K10067]
            6441  SFTPD; surfactant protein D [KO:K10068]
            3685  ITGAV; integrin subunit alpha V [KO:K06487]
            3673  ITGA2; integrin subunit alpha 2 [KO:K06481]
            3678  ITGA5; integrin subunit alpha 5 [KO:K06484]
            3688  ITGB1; integrin subunit beta 1 [KO:K05719]
            3690  ITGB3; integrin subunit beta 3 [KO:K06493]
            3693  ITGB5; integrin subunit beta 5 [KO:K06588]
            7057  THBS1; thrombospondin 1 [KO:K16857]
            1311  COMP; cartilage oligomeric matrix protein [KO:K04659]
            7058  THBS2; thrombospondin 2 [KO:K04659]
            7059  THBS3; thrombospondin 3 [KO:K04659]
            7060  THBS4; thrombospondin 4 [KO:K04659]
            7097  TLR2; toll like receptor 2 [KO:K10159]
            10333  TLR6; toll like receptor 6 [KO:K10169]
            7099  TLR4; toll like receptor 4 [KO:K10160]
            929  CD14; CD14 molecule [KO:K04391]
            22925  PLA2R1; phospholipase A2 receptor 1 [KO:K06560]
            4360  MRC1; mannose receptor, C type 1 [KO:K06560]
            9902  MRC2; mannose receptor, C type 2 [KO:K06560]
            10332  CLEC4M; C-type lectin domain family 4 member M [KO:K06563]
            30835  CD209; CD209 molecule [KO:K06563]
            64581  CLEC7A; C-type lectin domain family 7 member A [KO:K10074]
            4481  MSR1; macrophage scavenger receptor 1 [KO:K06558]
            8685  MARCO; macrophage receptor with collagenous structure [KO:K13884]
            4973  OLR1; oxidized low density lipoprotein receptor 1 [KO:K08763]
            949  SCARB1; scavenger receptor class B member 1 [KO:K13885]
            948  CD36; CD36 molecule [KO:K06259]
            1535  CYBA; cytochrome b-245 alpha chain [KO:K08009]
            50508  NOX3; NADPH oxidase 3 [KO:K08008]
            27035  NOX1; NADPH oxidase 1 [KO:K08008]
            1536  CYBB; cytochrome b-245, beta polypeptide [KO:K08008]
            5879  RAC1; ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) [KO:K04392]
            653361  NCF1; neutrophil cytosolic factor 1 [KO:K08011]
            4688  NCF2; neutrophil cytosolic factor 2 [KO:K08010]
            4689  NCF4; neutrophil cytosolic factor 4 [KO:K08012]
COMPOUND    C04549  1-Phosphatidyl-1D-myo-inositol 3-phosphate
REFERENCE   PMID:15894272
  AUTHORS   Stuart LM, Ezekowitz RA
  TITLE     Phagocytosis: elegant complexity.
  JOURNAL   Immunity 22:539-50 (2005)
REFERENCE   PMID:10684585
  AUTHORS   Tjelle TE, Lovdal T, Berg T
  TITLE     Phagosome dynamics and function.
  JOURNAL   Bioessays 22:255-63 (2000)
REFERENCE   PMID:18492791
  AUTHORS   Dupuy AG, Caron E
  TITLE     Integrin-dependent phagocytosis: spreading from microadhesion to new concepts.
  JOURNAL   J Cell Sci 121:1773-83 (2008)
REFERENCE   PMID:15036145
  AUTHORS   Brumell JH, Grinstein S
  TITLE     Salmonella redirects phagosomal maturation.
  JOURNAL   Curr Opin Microbiol 7:78-84 (2004)
REFERENCE   PMID:17245426
  AUTHORS   Huynh KK, Eskelinen EL, Scott CC, Malevanets A, Saftig P, Grinstein S
  TITLE     LAMP proteins are required for fusion of lysosomes with phagosomes.
  JOURNAL   EMBO J 26:313-24 (2007)
REFERENCE   PMID:17637737
  AUTHORS   Luzio JP, Pryor PR, Bright NA
  TITLE     Lysosomes: fusion and function.
  JOURNAL   Nat Rev Mol Cell Biol 8:622-32 (2007)
REFERENCE   PMID:18513324
  AUTHORS   Sumimoto H
  TITLE     Structure, regulation and evolution of Nox-family NADPH oxidases that produce reactive oxygen species.
  JOURNAL   FEBS J 275:3249-77 (2008)
KO_PATHWAY  ko04145
///
ENTRY       hsa04142                    Pathway
NAME        Lysosome - Homo sapiens (human)
DESCRIPTION Lysosomes are membrane-delimited organelles in animal cells serving as the cell's main digestive compartment to which all sorts of macromolecules are delivered for degradation. They contain more than 40 hydrolases in an acidic environment (pH of about 5). After synthesis in the ER, lysosomal enzymes are decorated with mannose-6-phosphate residues, which are recognized by mannose-6-phosphate receptors in the trans-Golgi network. They are packaged into clathrin-coated vesicles and are transported to late endosomes. Substances for digestion are acquired by the lysosomes via a series of processes including endocytosis, phagocytosis, and autophagy.
CLASS       Cellular Processes; Transport and catabolism
PATHWAY_MAP hsa04142  Lysosome
DISEASE     H00123  Mucopolysaccharidosis type IV (MPS4)
            H00124  GM2 gangliosidoses
            H00125  Fabry disease
            H00126  Gaucher disease
            H00127  Metachromatic leukodystrophy (MLD)
            H00128  Mucopolysaccharidosis type I (MPS1)
            H00129  Mucopolysaccharidosis type II (MPS2)
            H00130  Mucopolysaccharidosis type III (MPS3)
            H00131  Mucopolysaccharidosis type VI (MPS6)
            H00132  Mucopolysaccharidosis type VII (MPS7)
            H00133  Mucopolysaccharidosis type IX (MPS9)
            H00135  Krabbe disease
            H00136  Niemann-Pick disease type C (NPC)
            H00137  Niemann-Pick disease (NPD) typeA and B
            H00138  Farber lipogranulomatosis
            H00139  alpha-Mannosidosis
            H00140  beta-Mannosidosis
            H00141  Fucosidosis
            H00142  Sialidosis
            H00143  Mucolipidosis II and III
            H00144  Mucolipidosis IV
            H00145  Aspartylglucosaminuria (AGU)
            H00146  Alpha-N-acetylgalactosaminidase deficiency
            H00147  Sialuria/ Sialic acid storage disease
            H00148  Lysosomal acid lipase deficiency
            H00149  Neuronal ceroid lipofuscinosis
            H00150  Danon disease
            H00166  Hermansky-Pudlak syndrome (HPS)
            H00272  Multiple sulfatase deficiency (MSD)
            H00273  Pycnodysostosis
            H00274  Papillon-Lefevre syndrome
            H00275  Cystinosis
            H00276  Galactosialidosis
            H00281  GM1 gangliosidosis
            H00421  Mucopolysaccharidosis (MPS)
            H00422  Glycoproteinoses
            H00423  Defects in the degradation of sulfatide
            H00424  Defects in the degradation of sphingomyelin
            H00425  Lysosomal cysteine protease deficiencies
            H00426  Defects in the degradation of ganglioside
            H00696  Haim-Munk syndrome
            H00810  Progressive myoclonic epilepsy (PME/ EPM)
            H00932  Tropical calcific pancreatitis
            H01097  Cerebral palsy
            H01113  Acid phosphatase deficiency
            H01196  Hypochromic microcytic anemia
            H01239  Combined SAP deficiency
            H01425  Lysosomal storage diseases
DRUG        D06634  Relacatib (USAN/INN)
            D08955  Odanacatib (JAN/USAN)
DBLINKS     BSID: 99052
            GO: 0005764
ORGANISM    Homo sapiens (human) [GN:hsa]
GENE        10312  TCIRG1; T-cell immune regulator 1, ATPase H+ transporting V0 subunit a3 [KO:K02154]
            23545  ATP6V0A2; ATPase H+ transporting V0 subunit a2 [KO:K02154]
            50617  ATP6V0A4; ATPase H+ transporting V0 subunit a4 [KO:K02154]
            535  ATP6V0A1; ATPase H+ transporting V0 subunit a1 [KO:K02154]
            9114  ATP6V0D1; ATPase H+ transporting V0 subunit d1 [KO:K02146]
            245972  ATP6V0D2; ATPase H+ transporting V0 subunit d2 [KO:K02146]
            51606  ATP6V1H; ATPase H+ transporting V1 subunit H [KO:K02144]
            537  ATP6AP1; ATPase H+ transporting accessory protein 1 [KO:K03662]
            527  ATP6V0C; ATPase H+ transporting V0 subunit c [KO:K02155]
            533  ATP6V0B; ATPase H+ transporting V0 subunit b [KO:K03661]
            5476  CTSA; cathepsin A [KO:K13289] [EC:3.4.16.5]
            1508  CTSB; cathepsin B [KO:K01363] [EC:3.4.22.1]
            1075  CTSC; cathepsin C [KO:K01275] [EC:3.4.14.1]
            1509  CTSD; cathepsin D [KO:K01379] [EC:3.4.23.5]
            1510  CTSE; cathepsin E [KO:K01382] [EC:3.4.23.34]
            8722  CTSF; cathepsin F [KO:K01373] [EC:3.4.22.41]
            1511  CTSG; cathepsin G [KO:K01319] [EC:3.4.21.20]
            1512  CTSH; cathepsin H [KO:K01366] [EC:3.4.22.16]
            1513  CTSK; cathepsin K [KO:K01371] [EC:3.4.22.38]
            1514  CTSL; cathepsin L [KO:K01365] [EC:3.4.22.15]
            1519  CTSO; cathepsin O [KO:K01374] [EC:3.4.22.42]
            1520  CTSS; cathepsin S [KO:K01368] [EC:3.4.22.27]
            1515  CTSV; cathepsin V [KO:K01375] [EC:3.4.22.43]
            1521  CTSW; cathepsin W [KO:K08569] [EC:3.4.22.-]
            1522  CTSZ; cathepsin Z [KO:K08568] [EC:3.4.18.1]
            9476  NAPSA; napsin A aspartic peptidase [KO:K08565] [EC:3.4.23.-]
            5641  LGMN; legumain [KO:K01369] [EC:3.4.22.34]
            1200  TPP1; tripeptidyl peptidase I [KO:K01279] [EC:3.4.14.9]
            2717  GLA; galactosidase alpha [KO:K01189] [EC:3.2.1.22]
            2720  GLB1; galactosidase beta 1 [KO:K12309] [EC:3.2.1.23]
            2548  GAA; glucosidase, alpha [KO:K12316] [EC:3.2.1.20]
            2629  GBA; glucosylceramidase beta [KO:K01201] [EC:3.2.1.45]
            3425  IDUA; iduronidase, alpha-L- [KO:K01217] [EC:3.2.1.76]
            4668  NAGA; N-acetylgalactosaminidase, alpha- [KO:K01204] [EC:3.2.1.49]
            4669  NAGLU; N-acetylglucosaminidase, alpha [KO:K01205] [EC:3.2.1.50]
            2581  GALC; galactosylceramidase [KO:K01202] [EC:3.2.1.46]
            2990  GUSB; glucuronidase beta [KO:K01195] [EC:3.2.1.31]
            3073  HEXA; hexosaminidase subunit alpha [KO:K12373] [EC:3.2.1.52]
            3074  HEXB; hexosaminidase subunit beta [KO:K12373] [EC:3.2.1.52]
            4126  MANBA; mannosidase beta [KO:K01192] [EC:3.2.1.25]
            4125  MAN2B1; mannosidase alpha class 2B member 1 [KO:K12311] [EC:3.2.1.24]
            4758  NEU1; neuraminidase 1 (lysosomal sialidase) [KO:K01186] [EC:3.2.1.18]
            410  ARSA; arylsulfatase A [KO:K01134] [EC:3.1.6.8]
            411  ARSB; arylsulfatase B [KO:K01135] [EC:3.1.6.12]
            22901  ARSG; arylsulfatase G [KO:K12381] [EC:3.1.6.-]
            2588  GALNS; galactosamine (N-acetyl)-6-sulfatase [KO:K01132] [EC:3.1.6.4]
            2799  GNS; glucosamine (N-acetyl)-6-sulfatase [KO:K01137] [EC:3.1.6.14]
            3423  IDS; iduronate 2-sulfatase [KO:K01136] [EC:3.1.6.13]
            6448  SGSH; N-sulfoglucosamine sulfohydrolase [KO:K01565] [EC:3.10.1.1]
            3988  LIPA; lipase A, lysosomal acid type [KO:K01052] [EC:3.1.1.13]
            23659  PLA2G15; phospholipase A2 group XV [KO:K06129] [EC:3.1.1.5]
            1777  DNASE2; deoxyribonuclease II, lysosomal [KO:K01158] [EC:3.1.22.1]
            58511  DNASE2B; deoxyribonuclease II beta [KO:K01158] [EC:3.1.22.1]
            53  ACP2; acid phosphatase 2, lysosomal [KO:K14410] [EC:3.1.3.2]
            54  ACP5; acid phosphatase 5, tartrate resistant [KO:K14379] [EC:3.1.3.2]
            6609  SMPD1; sphingomyelin phosphodiesterase 1 [KO:K12350] [EC:3.1.4.12]
            427  ASAH1; N-acylsphingosine amidohydrolase (acid ceramidase) 1 [KO:K12348] [EC:3.5.1.23]
            175  AGA; aspartylglucosaminidase [KO:K01444] [EC:3.5.1.26]
            5660  PSAP; prosaposin [KO:K12382]
            768239  PSAPL1; prosaposin-like 1 (gene/pseudogene) [KO:K12382]
            2760  GM2A; GM2 ganglioside activator [KO:K12383]
            5538  PPT1; palmitoyl-protein thioesterase 1 [KO:K01074] [EC:3.1.2.22]
            9374  PPT2; palmitoyl-protein thioesterase 2 [KO:K01074] [EC:3.1.2.22]
            3916  LAMP1; lysosomal associated membrane protein 1 [KO:K06528]
            3920  LAMP2; lysosomal associated membrane protein 2 [KO:K06528]
            27074  LAMP3; lysosomal associated membrane protein 3 [KO:K06562]
            968  CD68; CD68 molecule [KO:K06501]
            967  CD63; CD63 molecule [KO:K06497]
            950  SCARB2; scavenger receptor class B member 2 [KO:K12384]
            4864  NPC1; Niemann-Pick disease, type C1 [KO:K12385]
            10577  NPC2; Niemann-Pick disease, type C2 [KO:K13443]
            1497  CTNS; cystinosin, lysosomal cystine transporter [KO:K12386]
            26503  SLC17A5; solute carrier family 17 member 5 [KO:K12301]
            6556  SLC11A1; solute carrier family 11 member 1 [KO:K12347]
            4891  SLC11A2; solute carrier family 11 member 2 [KO:K12347]
            55353  LAPTM4B; lysosomal protein transmembrane 4 beta [KO:K12387]
            7805  LAPTM5; lysosomal protein transmembrane 5 [KO:K12387]
            9741  LAPTM4A; lysosomal protein transmembrane 4 alpha [KO:K12387]
            20  ABCA2; ATP binding cassette subfamily A member 2 [KO:K05642]
            23457  ABCB9; ATP binding cassette subfamily B member 9 [KO:K05656]
            8763  CD164; CD164 molecule [KO:K06546]
            9583  ENTPD4; ectonucleoside triphosphate diphosphohydrolase 4 [KO:K12305] [EC:3.6.1.6]
            6272  SORT1; sortilin 1 [KO:K12388]
            1201  CLN3; ceroid-lipofuscinosis, neuronal 3 [KO:K12389]
            1203  CLN5; ceroid-lipofuscinosis, neuronal 5 [KO:K12390]
            256471  MFSD8; major facilitator superfamily domain containing 8 [KO:K12307]
            138050  HGSNAT; heparan-alpha-glucosaminide N-acetyltransferase [KO:K10532] [EC:2.3.1.78]
            285362  SUMF1; sulfatase modifying factor 1 [KO:K13444]
            79158  GNPTAB; N-acetylglucosamine-1-phosphate transferase alpha and beta subunits [KO:K08239] [EC:2.7.8.17]
            84572  GNPTG; N-acetylglucosamine-1-phosphate transferase gamma subunit [KO:K10087]
            51172  NAGPA; N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase [KO:K01125] [EC:3.1.4.45]
            3482  IGF2R; insulin like growth factor 2 receptor [KO:K06564]
            4074  M6PR; mannose-6-phosphate receptor, cation dependent [KO:K10089]
            1211  CLTA; clathrin light chain A [KO:K04644]
            1212  CLTB; clathrin light chain B [KO:K04645]
            1213  CLTC; clathrin heavy chain [KO:K04646]
            8218  CLTCL1; clathrin heavy chain like 1 [KO:K04646]
            164  AP1G1; adaptor related protein complex 1 gamma 1 subunit [KO:K12391]
            8906  AP1G2; adaptor related protein complex 1 gamma 2 subunit [KO:K12391]
            162  AP1B1; adaptor related protein complex 1 beta 1 subunit [KO:K12392]
            8907  AP1M1; adaptor related protein complex 1 mu 1 subunit [KO:K12393]
            10053  AP1M2; adaptor related protein complex 1 mu 2 subunit [KO:K12393]
            1174  AP1S1; adaptor related protein complex 1 sigma 1 subunit [KO:K12394]
            8905  AP1S2; adaptor related protein complex 1 sigma 2 subunit [KO:K12394]
            130340  AP1S3; adaptor related protein complex 1 sigma 3 subunit [KO:K12395]
            8943  AP3D1; adaptor related protein complex 3 delta 1 subunit [KO:K12396]
            8120  AP3B2; adaptor related protein complex 3 beta 2 subunit [KO:K12397]
            8546  AP3B1; adaptor related protein complex 3 beta 1 subunit [KO:K12397]
            26985  AP3M1; adaptor related protein complex 3 mu 1 subunit [KO:K12398]
            10947  AP3M2; adaptor related protein complex 3 mu 2 subunit [KO:K12398]
            10239  AP3S2; adaptor related protein complex 3 sigma 2 subunit [KO:K12399]
            1176  AP3S1; adaptor related protein complex 3 sigma 1 subunit [KO:K12399]
            23431  AP4E1; adaptor related protein complex 4 epsilon 1 subunit [KO:K12400]
            10717  AP4B1; adaptor related protein complex 4 beta 1 subunit [KO:K12401]
            9179  AP4M1; adaptor related protein complex 4 mu 1 subunit [KO:K12402]
            11154  AP4S1; adaptor related protein complex 4 sigma 1 subunit [KO:K12403]
            23062  GGA2; golgi associated, gamma adaptin ear containing, ARF binding protein 2 [KO:K12404]
            23163  GGA3; golgi-associated, gamma adaptin ear containing, ARF binding protein 3 [KO:K12404]
            26088  GGA1; golgi-associated, gamma adaptin ear containing, ARF binding protein 1 [KO:K12404]
            57192  MCOLN1; mucolipin 1 [KO:K04992]
            9516  LITAF; lipopolysaccharide induced TNF factor [KO:K19363]
            2517  FUCA1; fucosidase, alpha-L- 1, tissue [KO:K01206] [EC:3.2.1.51]
            3373  HYAL1; hyaluronoglucosaminidase 1 [KO:K01197] [EC:3.2.1.35]
COMPOUND    C00002  ATP
            C00008  ADP
            C00159  D-Mannose
            C00275  D-Mannose 6-phosphate
REFERENCE   
  AUTHORS   Alberts B,  Johnson A, Lewis J, Raff M, Roberts K, Walter P
  TITLE     Molecular Biology of the Cell 4th ed.
  JOURNAL   Garland Science (2002)
REFERENCE   PMID:12628346
  AUTHORS   Eskelinen EL, Tanaka Y, Saftig P
  TITLE     At the acidic edge: emerging functions for lysosomal membrane proteins.
  JOURNAL   Trends Cell Biol 13:137-45 (2003)
REFERENCE   PMID:1883197
  AUTHORS   Neufeld EF
  TITLE     Lysosomal storage diseases.
  JOURNAL   Annu Rev Biochem 60:257-80 (1991)
REFERENCE   PMID:2943218
  AUTHORS   von Figura K, Hasilik A
  TITLE     Lysosomal enzymes and their receptors.
  JOURNAL   Annu Rev Biochem 55:167-93 (1986)
REFERENCE   
  AUTHORS   Uchiyama Y.
  TITLE     [The analysis of a knockout mouse.] ( In Japanese)
  JOURNAL   Cell Technology 25:1322-27 (2006)
REFERENCE   PMID:15987739
  AUTHORS   Janvier K, Bonifacino JS
  TITLE     Role of the endocytic machinery in the sorting of lysosome-associated membrane proteins.
  JOURNAL   Mol Biol Cell 16:4231-42 (2005)
REFERENCE   PMID:18635948
  AUTHORS   Vergarajauregui S, Puertollano R
  TITLE     Mucolipidosis type IV: the importance of functional lysosomes for efficient autophagy.
  JOURNAL   Autophagy 4:832-4 (2008)
KO_PATHWAY  ko04142
///
ENTRY       hsa04110                    Pathway
NAME        Cell cycle - Homo sapiens (human)
DESCRIPTION Mitotic cell cycle progression is accomplished through a reproducible sequence of events, DNA replication (S phase) and mitosis (M phase) separated temporally by gaps known as G1 and G2 phases. Cyclin-dependent kinases (CDKs) are key regulatory enzymes, each consisting of a catalytic CDK subunit and an activating cyclin subunit. CDKs regulate the cell's progression through the phases of the cell cycle by modulating the activity of key substrates. Downstream targets of CDKs include transcription factor E2F and its regulator Rb. Precise activation and inactivation of CDKs at specific points in the cell cycle are required for orderly cell division. Cyclin-CDK inhibitors (CKIs), such as p16Ink4a, p15Ink4b, p27Kip1, and p21Cip1, are involved in the negative regulation of CDK activities, thus providing a pathway through which the cell cycle is negatively regulated.
             Eukaryotic cells respond to DNA damage by activating signaling pathways that promote cell cycle arrest and DNA repair. In response to DNA damage, the checkpoint kinase ATM phosphorylates and activates Chk2, which in turn directly phosphorylates and activates p53 tumor suppressor protein. p53 and its transcriptional targets play an important role in both G1 and G2 checkpoints. ATR-Chk1-mediated protein degradation of Cdc25A protein phosphatase is also a mechanism conferring intra-S-phase checkpoint activation.
CLASS       Cellular Processes; Cell growth and death
PATHWAY_MAP hsa04110  Cell cycle
MODULE      hsa_M00284  Origin recognition complex [PATH:hsa04110]
            hsa_M00285  MCM complex [PATH:hsa04110]
            hsa_M00297  DNA-PK complex [PATH:hsa04110]
            hsa_M00381  SCF-SKP2 complex [PATH:hsa04110]
            hsa_M00389  APC/C complex [PATH:hsa04110]
            hsa_M00691  DNA damage-induced cell cycle checkpoints [PATH:hsa04110]
            hsa_M00692  Cell cycle - G1/S transition [PATH:hsa04110]
            hsa_M00693  Cell cycle - G2/M transition [PATH:hsa04110]
DISEASE     H00409  Type II diabetes mellitus
            H00631  Cornelia de Lange syndrome (CdLS)
            H00713  Beckwith-Wiedemann syndrome
            H00848  Ataxia with ocular apraxia (AOA)
            H00881  Li-Fraumeni syndrome
            H00992  Seckel syndrome
            H01007  Choroid plexus papilloma
            H01023  Juvenile polyposis syndrome
            H01102  Pituitary adenomas
            H01288  Mosaic variegated aneuploidy (MVA) syndrome
            H01385  Rienhoff syndrome
            H01509  Tonsillar cancer
            H01513  Retinoblastoma
DRUG        D06320  Vorinostat (JAN/USAN)
            D06413  Nilotinib hydrochloride hydrate (JAN)
            D06637  Romidepsin (JAN/USAN/INN)
            D08870  Belinostat (USAN/INN)
            D08953  Nilotinib (USAN/INN)
            D09338  Entinostat (USAN/INN)
            D09357  Mocetinostat dihydrobromide (USAN)
            D09604  Dinaciclib (USAN/INN)
            D09641  Mocetinostat (USAN/INN)
            D10019  Panobinostat lactate (JAN)
            D10060  Abexinostat (USAN)
            D10084  Abexinostat hydrochloride (USAN)
            D10154  Rigosertib (USAN)
            D10155  Rigosertib sodium (USAN)
            D10182  Volasertib (USAN)
            D10183  Volasertib hydrochloride (JAN)
            D10319  Panobinostat (USAN/INN)
            D10372  Palbociclib (JAN/USAN)
            D10397  Rabusertib (USAN/INN)
DBLINKS     BSID: 83054
            GO: 0000278
ORGANISM    Homo sapiens (human) [GN:hsa]
GENE        595  CCND1; cyclin D1 [KO:K04503]
            894  CCND2; cyclin D2 [KO:K10151]
            896  CCND3; cyclin D3 [KO:K10152]
            1019  CDK4; cyclin-dependent kinase 4 [KO:K02089] [EC:2.7.11.22]
            1021  CDK6; cyclin-dependent kinase 6 [KO:K02091] [EC:2.7.11.22]
            5925  RB1; retinoblastoma 1 [KO:K06618]
            5933  RBL1; retinoblastoma-like 1 [KO:K04681]
            5934  RBL2; retinoblastoma-like 2 [KO:K16332]
            25  ABL1; ABL proto-oncogene 1, non-receptor tyrosine kinase [KO:K06619] [EC:2.7.10.2]
            3065  HDAC1; histone deacetylase 1 [KO:K06067] [EC:3.5.1.98]
            3066  HDAC2; histone deacetylase 2 [KO:K06067] [EC:3.5.1.98]
            1869  E2F1; E2F transcription factor 1 [KO:K17454]
            1870  E2F2; E2F transcription factor 2 [KO:K09389]
            1871  E2F3; E2F transcription factor 3 [KO:K06620]
            1874  E2F4; E2F transcription factor 4 [KO:K04682]
            1875  E2F5; E2F transcription factor 5 [KO:K04682]
            7027  TFDP1; transcription factor Dp-1 [KO:K04683]
            7029  TFDP2; transcription factor Dp-2 (E2F dimerization partner 2) [KO:K09392]
            2932  GSK3B; glycogen synthase kinase 3 beta [KO:K03083] [EC:2.7.11.26]
            7040  TGFB1; transforming growth factor beta 1 [KO:K13375]
            7042  TGFB2; transforming growth factor beta 2 [KO:K13376]
            7043  TGFB3; transforming growth factor beta 3 [KO:K13377]
            4087  SMAD2; SMAD family member 2 [KO:K04500]
            4088  SMAD3; SMAD family member 3 [KO:K04500]
            4089  SMAD4; SMAD family member 4 [KO:K04501]
            4609  MYC; v-myc avian myelocytomatosis viral oncogene homolog [KO:K04377]
            7709  ZBTB17; zinc finger and BTB domain containing 17 [KO:K10500]
            1029  CDKN2A; cyclin-dependent kinase inhibitor 2A [KO:K06621]
            1030  CDKN2B; cyclin-dependent kinase inhibitor 2B [KO:K04685]
            1031  CDKN2C; cyclin-dependent kinase inhibitor 2C [KO:K06622]
            1032  CDKN2D; cyclin-dependent kinase inhibitor 2D [KO:K06623]
            1027  CDKN1B; cyclin-dependent kinase inhibitor 1B [KO:K06624]
            1028  CDKN1C; cyclin-dependent kinase inhibitor 1C [KO:K09993]
            1026  CDKN1A; cyclin-dependent kinase inhibitor 1A [KO:K06625]
            898  CCNE1; cyclin E1 [KO:K06626]
            9134  CCNE2; cyclin E2 [KO:K06626]
            1017  CDK2; cyclin-dependent kinase 2 [KO:K02206] [EC:2.7.11.22]
            6500  SKP1; S-phase kinase-associated protein 1 [KO:K03094]
            8454  CUL1; cullin 1 [KO:K03347]
            9978  RBX1; ring-box 1, E3 ubiquitin protein ligase [KO:K03868]
            6502  SKP2; S-phase kinase-associated protein 2, E3 ubiquitin protein ligase [KO:K03875]
            890  CCNA2; cyclin A2 [KO:K06627]
            8900  CCNA1; cyclin A1 [KO:K06627]
            990  CDC6; cell division cycle 6 [KO:K02213]
            8318  CDC45; cell division cycle 45 [KO:K06628]
            8317  CDC7; cell division cycle 7 [KO:K02214] [EC:2.7.11.1]
            10926  DBF4; DBF4 zinc finger [KO:K06629]
            983  CDK1; cyclin-dependent kinase 1 [KO:K02087] [EC:2.7.11.23 2.7.11.22]
            891  CCNB1; cyclin B1 [KO:K05868]
            9133  CCNB2; cyclin B2 [KO:K05868]
            85417  CCNB3; cyclin B3 [KO:K05868]
            994  CDC25B; cell division cycle 25B [KO:K05866] [EC:3.1.3.48]
            995  CDC25C; cell division cycle 25C [KO:K05867] [EC:3.1.3.48]
            7534  YWHAZ; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta [KO:K16197]
            7529  YWHAB; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta [KO:K16197]
            10971  YWHAQ; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta [KO:K16197]
            7531  YWHAE; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon [KO:K06630]
            7533  YWHAH; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta [KO:K16198]
            7532  YWHAG; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma [KO:K16198]
            5347  PLK1; polo like kinase 1 [KO:K06631] [EC:2.7.11.21]
            7465  WEE1; WEE1 G2 checkpoint kinase [KO:K06632] [EC:2.7.11.1]
            494551  WEE2; WEE1 homolog 2 (S. pombe) [KO:K06632] [EC:2.7.11.1]
            9088  PKMYT1; protein kinase, membrane associated tyrosine/threonine 1 [KO:K06633] [EC:2.7.11.1]
            902  CCNH; cyclin H [KO:K06634]
            1022  CDK7; cyclin-dependent kinase 7 [KO:K02202] [EC:2.7.11.23 2.7.11.22]
            64682  ANAPC1; anaphase promoting complex subunit 1 [KO:K03348]
            29882  ANAPC2; anaphase promoting complex subunit 2 [KO:K03349]
            996  CDC27; cell division cycle 27 [KO:K03350]
            29945  ANAPC4; anaphase promoting complex subunit 4 [KO:K03351]
            51433  ANAPC5; anaphase promoting complex subunit 5 [KO:K03352]
            8881  CDC16; cell division cycle 16 [KO:K03353]
            51434  ANAPC7; anaphase promoting complex subunit 7 [KO:K03354]
            8697  CDC23; cell division cycle 23 [KO:K03355]
            10393  ANAPC10; anaphase promoting complex subunit 10 [KO:K03357]
            51529  ANAPC11; anaphase promoting complex subunit 11 [KO:K03358]
            246184  CDC26; cell division cycle 26 [KO:K03359]
            25847  ANAPC13; anaphase promoting complex subunit 13 [KO:K12456]
            991  CDC20; cell division cycle 20 [KO:K03363]
            9232  PTTG1; pituitary tumor-transforming 1 [KO:K06635]
            10744  PTTG2; pituitary tumor-transforming 2 [KO:K06635]
            9700  ESPL1; extra spindle pole bodies like 1, separase [KO:K02365] [EC:3.4.22.49]
            8243  SMC1A; structural maintenance of chromosomes 1A [KO:K06636]
            27127  SMC1B; structural maintenance of chromosomes 1B [KO:K06636]
            9126  SMC3; structural maintenance of chromosomes 3 [KO:K06669]
            10735  STAG2; stromal antigen 2 [KO:K06671]
            10274  STAG1; stromal antigen 1 [KO:K06671]
            5885  RAD21; RAD21 cohesin complex component [KO:K06670]
            7272  TTK; TTK protein kinase [KO:K08866] [EC:2.7.12.1]
            699  BUB1; BUB1 mitotic checkpoint serine/threonine kinase [KO:K02178] [EC:2.7.11.1]
            9184  BUB3; BUB3, mitotic checkpoint protein [KO:K02180]
            701  BUB1B; BUB1 mitotic checkpoint serine/threonine kinase B [KO:K06637] [EC:2.7.11.1]
            8379  MAD1L1; MAD1 mitotic arrest deficient-like 1 (yeast) [KO:K06638]
            4085  MAD2L1; MAD2 mitotic arrest deficient-like 1 (yeast) [KO:K02537]
            10459  MAD2L2; MAD2 mitotic arrest deficient-like 2 (yeast) [KO:K13728]
            51343  FZR1; fizzy/cell division cycle 20 related 1 [KO:K03364]
            8555  CDC14B; cell division cycle 14B [KO:K06639] [EC:3.1.3.48 3.1.3.16]
            8556  CDC14A; cell division cycle 14A [KO:K06639] [EC:3.1.3.48 3.1.3.16]
            545  ATR; ATR serine/threonine kinase [KO:K06640] [EC:2.7.11.1]
            472  ATM; ATM serine/threonine kinase [KO:K04728] [EC:2.7.11.1]
            7157  TP53; tumor protein p53 [KO:K04451]
            1111  CHEK1; checkpoint kinase 1 [KO:K02216] [EC:2.7.11.1]
            11200  CHEK2; checkpoint kinase 2 [KO:K06641] [EC:2.7.11.1]
            1387  CREBBP; CREB binding protein [KO:K04498] [EC:2.3.1.48]
            2033  EP300; E1A binding protein p300 [KO:K04498] [EC:2.3.1.48]
            5591  PRKDC; protein kinase, DNA-activated, catalytic polypeptide [KO:K06642] [EC:2.7.11.1]
            4193  MDM2; MDM2 proto-oncogene [KO:K06643] [EC:2.3.2.27]
            1647  GADD45A; growth arrest and DNA damage inducible alpha [KO:K04402]
            4616  GADD45B; growth arrest and DNA damage inducible beta [KO:K04402]
            10912  GADD45G; growth arrest and DNA damage inducible gamma [KO:K04402]
            5111  PCNA; proliferating cell nuclear antigen [KO:K04802]
            2810  SFN; stratifin [KO:K06644]
            993  CDC25A; cell division cycle 25A [KO:K06645] [EC:3.1.3.48]
            4998  ORC1; origin recognition complex subunit 1 [KO:K02603]
            4999  ORC2; origin recognition complex subunit 2 [KO:K02604]
            23595  ORC3; origin recognition complex subunit 3 [KO:K02605]
            5000  ORC4; origin recognition complex subunit 4 [KO:K02606]
            5001  ORC5; origin recognition complex subunit 5 [KO:K02607]
            23594  ORC6; origin recognition complex subunit 6 [KO:K02608]
            4171  MCM2; minichromosome maintenance complex component 2 [KO:K02540] [EC:3.6.4.12]
            4172  MCM3; minichromosome maintenance complex component 3 [KO:K02541] [EC:3.6.4.12]
            4173  MCM4; minichromosome maintenance complex component 4 [KO:K02212] [EC:3.6.4.12]
            4174  MCM5; minichromosome maintenance complex component 5 [KO:K02209] [EC:3.6.4.12]
            4175  MCM6; minichromosome maintenance complex component 6 [KO:K02542] [EC:3.6.4.12]
            4176  MCM7; minichromosome maintenance complex component 7 [KO:K02210] [EC:3.6.4.12]
REFERENCE   PMID:7908906
  AUTHORS   Matsuoka S, Yamaguchi M, Matsukage A
  TITLE     D-type cyclin-binding regions of proliferating cell nuclear antigen.
  JOURNAL   J Biol Chem 269:11030-6 (1994)
REFERENCE   PMID:8242749
  AUTHORS   Welch PJ, Wang JY
  TITLE     A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle.
  JOURNAL   Cell 75:779-90 (1993)
REFERENCE   PMID:16936746
  AUTHORS   Macaluso M, Montanari M, Giordano A
  TITLE     Rb family proteins as modulators of gene expression and new aspects regarding the interaction with chromatin remodeling enzymes.
  JOURNAL   Oncogene 25:5263-7 (2006)
REFERENCE   PMID:15838516
  AUTHORS   Cobrinik D
  TITLE     Pocket proteins and cell cycle control.
  JOURNAL   Oncogene 24:2796-809 (2005)
REFERENCE   PMID:17568790
  AUTHORS   Boutros R, Lobjois V, Ducommun B
  TITLE     CDC25 phosphatases in cancer cells: key players? Good targets?
  JOURNAL   Nat Rev Cancer 7:495-507 (2007)
REFERENCE   PMID:9832503
  AUTHORS   Diehl JA, Cheng M, Roussel MF, Sherr CJ
  TITLE     Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization.
  JOURNAL   Genes Dev 12:3499-511 (1998)
REFERENCE   PMID:19020303
  AUTHORS   Klein EA, Assoian RK
  TITLE     Transcriptional regulation of the cyclin D1 gene at a glance.
  JOURNAL   J Cell Sci 121:3853-7 (2008)
REFERENCE   PMID:10385618
  AUTHORS   Sherr CJ, Roberts JM
  TITLE     CDK inhibitors: positive and negative regulators of G1-phase progression.
  JOURNAL   Genes Dev 13:1501-12 (1999)
REFERENCE   PMID:12809600
  AUTHORS   Shi Y, Massague J.
  TITLE     Mechanisms of TGF-beta signaling from cell membrane to the nucleus.
  JOURNAL   Cell 113:685-700 (2003)
REFERENCE   PMID:12925736
  AUTHORS   Kamura T, Hara T, Kotoshiba S, Yada M, Ishida N, Imaki H, Hatakeyama S, Nakayama K, Nakayama KI
  TITLE     Degradation of p57Kip2 mediated by SCFSkp2-dependent ubiquitylation.
  JOURNAL   Proc Natl Acad Sci U S A 100:10231-6 (2003)
REFERENCE   PMID:16212951
  AUTHORS   Bond M, Sala-Newby GB, Wu YJ, Newby AC
  TITLE     Biphasic effect of p21Cip1 on smooth muscle cell proliferation: role of PI 3-kinase and Skp2-mediated degradation.
  JOURNAL   Cardiovasc Res 69:198-206 (2006)
REFERENCE   PMID:15838523
  AUTHORS   Harris SL, Levine AJ.
  TITLE     The p53 pathway: positive and negative feedback loops.
  JOURNAL   Oncogene 24:2899-908 (2005)
REFERENCE   PMID:11099028
  AUTHORS   Vogelstein B, Lane D, Levine AJ
  TITLE     Surfing the p53 network.
  JOURNAL   Nature 408:307-10 (2000)
REFERENCE   PMID:7973727
  AUTHORS   Smith ML, Chen IT, Zhan Q, Bae I, Chen CY, Gilmer TM, Kastan MB, O'Connor PM, Fornace AJ Jr
  TITLE     Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen.
  JOURNAL   Science 266:1376-80 (1994)
REFERENCE   PMID:9889196
  AUTHORS   Petersen BO, Lukas J, Sorensen CS, Bartek J, Helin K
  TITLE     Phosphorylation of mammalian CDC6 by cyclin A/CDK2 regulates its subcellular localization.
  JOURNAL   EMBO J 18:396-410 (1999)
REFERENCE   PMID:17018296
  AUTHORS   Sheu YJ, Stillman B
  TITLE     Cdc7-Dbf4 phosphorylates MCM proteins via a docking site-mediated mechanism to promote S phase progression.
  JOURNAL   Mol Cell 24:101-13 (2006)
REFERENCE   PMID:9029154
  AUTHORS   Martinez AM, Afshar M, Martin F, Cavadore JC, Labbe JC, Doree M
  TITLE     Dual phosphorylation of the T-loop in cdk7: its role in controlling cyclin H binding and CAK activity.
  JOURNAL   EMBO J 16:343-54 (1997)
REFERENCE   PMID:15876871
  AUTHORS   Lolli G, Johnson LN
  TITLE     CAK-Cyclin-dependent Activating Kinase: a key kinase in cell cycle control and a target for drugs?
  JOURNAL   Cell Cycle 4:572-7 (2005)
REFERENCE   PMID:17426725
  AUTHORS   Musacchio A, Salmon ED
  TITLE     The spindle-assembly checkpoint in space and time.
  JOURNAL   Nat Rev Mol Cell Biol 8:379-93 (2007)
REFERENCE   PMID:12573239
  AUTHORS   Uhlmann F
  TITLE     Chromosome cohesion and separation: from men and molecules.
  JOURNAL   Curr Biol 13:R104-14 (2003)
REFERENCE   PMID:15568976
  AUTHORS   Stegmeier F, Amon A
  TITLE     Closing mitosis: the functions of the Cdc14 phosphatase and its regulation.
  JOURNAL   Annu Rev Genet 38:203-32 (2004)
REFERENCE   PMID:9618481
  AUTHORS   Moustakas A, Kardassis D
  TITLE     Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members.
  JOURNAL   Proc Natl Acad Sci U S A 95:6733-8 (1998)
KO_PATHWAY  ko04110
///
ENTRY       hsa04210                    Pathway
NAME        Apoptosis - Homo sapiens (human)
DESCRIPTION Apoptosis is a genetically programmed process for the elimination of damaged or redundant cells by activation of caspases (aspartate-specific cysteine proteases). The onset of apoptosis is controlled by numerous interrelating processes. The 'extrinsic' pathway involves stimulation of members of the tumor necrosis factor (TNF) receptor subfamily, such as TNFRI, CD95/Fas or TRAILR (death receptors), located at the cell surface, by their specific ligands, such as TNF-alpha, FasL or TRAIL, respectively. The 'intrinsic' pathway is activated mainly by non-receptor stimuli, such as DNA damage, ER stress, metabolic stress, UV radiation or growth-factor deprivation. The central event in the 'intrinsic' pathway is the mitochondrial outer membrane permeabilization (MOMP), which leads to the release of cytochrome c. These two pathways converge at the level of effector caspases, such as caspase-3 and caspase-7. The third major pathway is initiated by the constituents of cytotoxic granules (e.g. Perforin and Granzyme B) that are released by CTLs (cytotoxic T-cells) and NK (natural killer) cells. Granzyme B, similarly to the caspases, cleaves its substrates after aspartic acid residues, suggesting that this protease has the ability to activate members of the caspase family directly. It is the balance between the pro-apoptotic and anti-apoptotic signals that eventually determines whether cells will undergo apoptosis, survive or proliferate. TNF family of ligands activates anti-apoptotic or cell-survival signals as well as apoptotic signals. NGF and Interleukin-3 promotes the survival, proliferation and differentiation of neurons or hematopoietic cells, respectively. Withdrawal of these growth factors leads to cell death, as described above.
CLASS       Cellular Processes; Cell growth and death
PATHWAY_MAP hsa04210  Apoptosis
MODULE      hsa_M00685  Apoptotic machinery [PATH:hsa04210]
DISEASE     H00108  Autoimmune lymphoproliferative syndromes (ALPS)
            H00265  Hereditary sensory and autonomic neuropathy (HSAN)
            H00539  PTEN hamartoma tumor syndrome (PHTS)
            H00540  Osteoporosis, lymphedema, anhydrotic ectodermal dysplasia with immunodeficiency (OLEDAID)
            H00645  Incontinentia pigmenti
            H00721  Pyogenic bacterial infections, recurrent, due to MYD88 deficiency
            H00848  Ataxia with ocular apraxia (AOA)
            H00881  Li-Fraumeni syndrome
            H00882  Cocoon syndrome
            H00912  Tumor necrosis factor receptor-associated periodic syndrome (TRAPS)
            H01007  Choroid plexus papilloma
            H01102  Pituitary adenomas
DRUG        D00742  Etanercept (genetical recombination) (JAN)
            D02597  Adalimumab (genetical recombination) (JAN)
            D02598  Infliximab (genetical recombination) (JAN)
            D02934  Anakinra (USAN/INN)
            D03441  Certolizumab pegol (genetical recombination) (JAN)
            D03645  Daniplestim (USAN/INN)
            D04695  Leridistim (USAN/INN)
            D04858  Mapatumumab (USAN/INN)
            D05090  Muplestim (genetical recombination) (JAN)
            D05146  Nerelimomab (USAN/INN)
            D05216  Oblimersen sodium (USAN)
            D06611  Lexatumumab (USAN/INN)
            D06635  Rilonacept (USAN/INN)
            D07436  Afelimomab (INN)
            D08290  Oblimersen (INN)
            D08954  Obatoclax mesylate (USAN)
            D09329  Conatumumab (USAN/INN)
            D09387  Tanezumab (USAN/INN)
            D09888  Drozitumab (USAN/INN)
            D09907  Fulranumab (USAN/INN)
            D10381  Afuresertib (USAN)
            D10382  Afuresertib hydrochloride (USAN)
DBLINKS     BSID: 83060
            GO: 0006915
ORGANISM    Homo sapiens (human) [GN:hsa]
GENE        8743  TNFSF10; tumor necrosis factor superfamily member 10 [KO:K04721]
            8797  TNFRSF10A; tumor necrosis factor receptor superfamily member 10a [KO:K04722]
            8795  TNFRSF10B; tumor necrosis factor receptor superfamily member 10b [KO:K04722]
            8794  TNFRSF10C; tumor necrosis factor receptor superfamily member 10c [KO:K04722]
            8793  TNFRSF10D; tumor necrosis factor receptor superfamily member 10d [KO:K04722]
            356  FASLG; Fas ligand [KO:K04389]
            355  FAS; Fas cell surface death receptor [KO:K04390]
            8772  FADD; Fas associated via death domain [KO:K02373]
            7124  TNF; tumor necrosis factor [KO:K03156]
            7132  TNFRSF1A; tumor necrosis factor receptor superfamily member 1A [KO:K03158]
            8717  TRADD; TNFRSF1A-associated via death domain [KO:K03171]
            8837  CFLAR; CASP8 and FADD like apoptosis regulator [KO:K04724]
            841  CASP8; caspase 8 [KO:K04398] [EC:3.4.22.61]
            843  CASP10; caspase 10 [KO:K04400] [EC:3.4.22.63]
            839  CASP6; caspase 6 [KO:K04396] [EC:3.4.22.59]
            836  CASP3; caspase 3 [KO:K02187] [EC:3.4.22.56]
            840  CASP7; caspase 7 [KO:K04397] [EC:3.4.22.60]
            637  BID; BH3 interacting domain death agonist [KO:K04726]
            581  BAX; BCL2-associated X protein [KO:K02159]
            578  BAK1; BCL2 antagonist/killer 1 [KO:K14021]
            56616  DIABLO; diablo IAP-binding mitochondrial protein [KO:K10522]
            5414  SEPT4; septin 4 [KO:K16943]
            27429  HTRA2; HtrA serine peptidase 2 [KO:K08669] [EC:3.4.21.108]
            54205  CYCS; cytochrome c, somatic [KO:K08738]
            317  APAF1; apoptotic peptidase activating factor 1 [KO:K02084]
            842  CASP9; caspase 9 [KO:K04399] [EC:3.4.22.62]
            5551  PRF1; perforin 1 [KO:K07818]
            3002  GZMB; granzyme B [KO:K01353] [EC:3.4.21.79]
            10376  TUBA1B; tubulin alpha 1b [KO:K07374]
            7277  TUBA4A; tubulin alpha 4a [KO:K07374]
            7278  TUBA3C; tubulin alpha 3c [KO:K07374]
            7846  TUBA1A; tubulin alpha 1a [KO:K07374]
            84790  TUBA1C; tubulin alpha 1c [KO:K07374]
            51807  TUBA8; tubulin alpha 8 [KO:K07374]
            112714  TUBA3E; tubulin alpha 3e [KO:K07374]
            113457  TUBA3D; tubulin alpha 3d [KO:K07374]
            79861  TUBAL3; tubulin alpha like 3 [KO:K07374]
            4170  MCL1; myeloid cell leukemia 1 [KO:K02539]
            60  ACTB; actin, beta [KO:K05692]
            71  ACTG1; actin gamma 1 [KO:K05692]
            6708  SPTA1; spectrin alpha, erythrocytic 1 [KO:K06114]
            6709  SPTAN1; spectrin alpha, non-erythrocytic 1 [KO:K06114]
            4000  LMNA; lamin A/C [KO:K12641]
            4001  LMNB1; lamin B1 [KO:K07611]
            84823  LMNB2; lamin B2 [KO:K07611]
            10038  PARP2; poly(ADP-ribose) polymerase 2 [KO:K10798] [EC:2.4.2.30]
            142  PARP1; poly(ADP-ribose) polymerase 1 [KO:K10798] [EC:2.4.2.30]
            10039  PARP3; poly(ADP-ribose) polymerase family member 3 [KO:K10798] [EC:2.4.2.30]
            143  PARP4; poly(ADP-ribose) polymerase family member 4 [KO:K10798] [EC:2.4.2.30]
            1676  DFFA; DNA fragmentation factor subunit alpha [KO:K02310]
            1677  DFFB; DNA fragmentation factor subunit beta [KO:K02311] [EC:3.-.-.-]
            2021  ENDOG; endonuclease G [KO:K01173]
            9131  AIFM1; apoptosis inducing factor, mitochondria associated 1 [KO:K04727] [EC:1.-.-.-]
            2081  ERN1; endoplasmic reticulum to nucleus signaling 1 [KO:K08852] [EC:3.1.26.- 2.7.11.1]
            7186  TRAF2; TNF receptor associated factor 2 [KO:K03173] [EC:2.3.2.27]
            3708  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 [KO:K04958]
            3709  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 [KO:K04959]
            3710  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]
            823  CAPN1; calpain 1 [KO:K01367] [EC:3.4.22.52]
            824  CAPN2; calpain 2 [KO:K03853] [EC:3.4.22.53]
            100506742  CASP12; caspase 12 (gene/pseudogene) [KO:K04741] [EC:3.4.22.-]
            9451  EIF2AK3; eukaryotic translation initiation factor 2 alpha kinase 3 [KO:K08860] [EC:2.7.11.1]
            1965  EIF2S1; eukaryotic translation initiation factor 2 subunit alpha [KO:K03237]
            468  ATF4; activating transcription factor 4 [KO:K04374]
            1649  DDIT3; DNA damage inducible transcript 3 [KO:K04452]
            1508  CTSB; cathepsin B [KO:K01363] [EC:3.4.22.1]
            1075  CTSC; cathepsin C [KO:K01275] [EC:3.4.14.1]
            1509  CTSD; cathepsin D [KO:K01379] [EC:3.4.23.5]
            8722  CTSF; cathepsin F [KO:K01373] [EC:3.4.22.41]
            1512  CTSH; cathepsin H [KO:K01366] [EC:3.4.22.16]
            1513  CTSK; cathepsin K [KO:K01371] [EC:3.4.22.38]
            1514  CTSL; cathepsin L [KO:K01365] [EC:3.4.22.15]
            1519  CTSO; cathepsin O [KO:K01374] [EC:3.4.22.42]
            1520  CTSS; cathepsin S [KO:K01368] [EC:3.4.22.27]
            1515  CTSV; cathepsin V [KO:K01375] [EC:3.4.22.43]
            1521  CTSW; cathepsin W [KO:K08569] [EC:3.4.22.-]
            1522  CTSZ; cathepsin Z [KO:K08568] [EC:3.4.18.1]
            329  BIRC2; baculoviral IAP repeat containing 2 [KO:K16060]
            330  BIRC3; baculoviral IAP repeat containing 3 [KO:K16060]
            331  XIAP; X-linked inhibitor of apoptosis [KO:K04725] [EC:2.3.2.27]
            332  BIRC5; baculoviral IAP repeat containing 5 [KO:K08731]
            10018  BCL2L11; BCL2 like 11 [KO:K16341]
            598  BCL2L1; BCL2 like 1 [KO:K04570]
            596  BCL2; B-cell CLL/lymphoma 2 [KO:K02161]
            1616  DAXX; death-domain associated protein [KO:K02308]
            8737  RIPK1; receptor interacting serine/threonine kinase 1 [KO:K02861] [EC:2.7.11.1]
            153090  DAB2IP; DAB2 interacting protein [KO:K19901]
            4217  MAP3K5; mitogen-activated protein kinase kinase kinase 5 [KO:K04426] [EC:2.7.11.25]
            5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]
            5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]
            5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]
            572  BAD; BCL2 associated agonist of cell death [KO:K02158]
            3725  JUN; jun proto-oncogene [KO:K04448]
            2353  FOS; FBJ murine osteosarcoma viral oncogene homolog [KO:K04379]
            7157  TP53; tumor protein p53 [KO:K04451]
            8739  HRK; harakiri, BCL2 interacting protein [KO:K02512]
            9020  MAP3K14; mitogen-activated protein kinase kinase kinase 14 [KO:K04466] [EC:2.7.11.25]
            1147  CHUK; conserved helix-loop-helix ubiquitous kinase [KO:K04467] [EC:2.7.11.10]
            3551  IKBKB; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta [KO:K07209] [EC:2.7.11.10]
            8517  IKBKG; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma [KO:K07210]
            4792  NFKBIA; NFKB inhibitor alpha [KO:K04734]
            4790  NFKB1; nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 [KO:K02580]
            5970  RELA; v-rel avian reticuloendotheliosis viral oncogene homolog A [KO:K04735]
            5783  PTPN13; protein tyrosine phosphatase, non-receptor type 13 [KO:K02374]
            1647  GADD45A; growth arrest and DNA damage inducible alpha [KO:K04402]
            4616  GADD45B; growth arrest and DNA damage inducible beta [KO:K04402]
            10912  GADD45G; growth arrest and DNA damage inducible gamma [KO:K04402]
            7185  TRAF1; TNF receptor associated factor 1 [KO:K03172]
            597  BCL2A1; BCL2 related protein A1 [KO:K02162]
            472  ATM; ATM serine/threonine kinase [KO:K04728] [EC:2.7.11.1]
            55367  PIDD1; p53-induced death domain protein 1 [KO:K10130]
            63970  TP53AIP1; tumor protein p53 regulated apoptosis inducing protein 1 [KO:K13773]
            27113  BBC3; BCL2 binding component 3 [KO:K10132]
            5366  PMAIP1; phorbol-12-myristate-13-acetate-induced protein 1 [KO:K10131]
            835  CASP2; caspase 2 [KO:K02186] [EC:3.4.22.55]
            4803  NGF; nerve growth factor [KO:K02582]
            4914  NTRK1; neurotrophic tyrosine kinase, receptor, type 1 [KO:K03176] [EC:2.7.10.1]
            3562  IL3; interleukin 3 [KO:K04736]
            3563  IL3RA; interleukin 3 receptor subunit alpha [KO:K04737]
            1439  CSF2RB; colony stimulating factor 2 receptor beta common subunit [KO:K04738]
            5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]
            5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]
            5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]
            5294  PIK3CG; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma [KO:K00922] [EC:2.7.1.153]
            5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]
            23533  PIK3R5; phosphoinositide-3-kinase regulatory subunit 5 [KO:K02649]
            5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]
            8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]
            5170  PDPK1; 3-phosphoinositide dependent protein kinase 1 [KO:K06276] [EC:2.7.11.1]
            207  AKT1; v-akt murine thymoma viral oncogene homolog 1 [KO:K04456] [EC:2.7.11.1]
            208  AKT2; v-akt murine thymoma viral oncogene homolog 2 [KO:K04456] [EC:2.7.11.1]
            10000  AKT3; v-akt murine thymoma viral oncogene homolog 3 [KO:K04456] [EC:2.7.11.1]
            3265  HRAS; Harvey rat sarcoma viral oncogene homolog [KO:K02833]
            3845  KRAS; Kirsten rat sarcoma viral oncogene homolog [KO:K07827]
            4893  NRAS; neuroblastoma RAS viral (v-ras) oncogene homolog [KO:K07828]
            5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]
            5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
            5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
            5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
            5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
COMPOUND    C00027  Hydrogen peroxide
            C00076  Calcium cation
            C00319  Sphingosine
            C05981  Phosphatidylinositol-3,4,5-trisphosphate
REFERENCE   PMID:26615431
  AUTHORS   Savitskaya MA, Onishchenko GE
  TITLE     Mechanisms of Apoptosis.
  JOURNAL   Biochemistry (Mosc) 80:1393-417 (2015)
REFERENCE   PMID:23803157
  AUTHORS   Schleich K, Lavrik IN
  TITLE     Mathematical modeling of apoptosis.
  JOURNAL   Cell Commun Signal 11:44 (2013)
REFERENCE   PMID:15654015
  AUTHORS   Lavrik I, Golks A, Krammer PH
  TITLE     Death receptor signaling.
  JOURNAL   J Cell Sci 118:265-7 (2005)
REFERENCE   PMID:15725726
  AUTHORS   Jin Z, El-Deiry WS
  TITLE     Overview of cell death signaling pathways.
  JOURNAL   Cancer Biol Ther 4:139-63 (2005)
REFERENCE   PMID:15322527
  AUTHORS   Benn SC, Woolf CJ
  TITLE     Adult neuron survival strategies--slamming on the brakes.
  JOURNAL   Nat Rev Neurosci 5:686-700 (2004)
REFERENCE   PMID:12838338
  AUTHORS   Orrenius S, Zhivotovsky B, Nicotera P
  TITLE     Regulation of cell death: the calcium-apoptosis link.
  JOURNAL   Nat Rev Mol Cell Biol 4:552-65 (2003)
REFERENCE   PMID:19148180
  AUTHORS   Clarke P, Tyler KL
  TITLE     Apoptosis in animal models of virus-induced disease.
  JOURNAL   Nat Rev Microbiol 7:144-55 (2009)
REFERENCE   PMID:22429822
  AUTHORS   Wen X, Lin ZQ, Liu B, Wei YQ
  TITLE     Caspase-mediated programmed cell death pathways as potential therapeutic targets  in cancer.
  JOURNAL   Cell Prolif 45:217-24 (2012)
REFERENCE   PMID:25526085
  AUTHORS   Shalini S, Dorstyn L, Dawar S, Kumar S
  TITLE     Old, new and emerging functions of caspases.
  JOURNAL   Cell Death Differ 22:526-39 (2015)
REFERENCE   PMID:15601572
  AUTHORS   Philchenkov A
  TITLE     Caspases: potential targets for regulating cell death.
  JOURNAL   J Cell Mol Med 8:432-44 (2004)
REFERENCE   PMID:9894605
  AUTHORS   Stroh C, Schulze-Osthoff K
  TITLE     Death by a thousand cuts: an ever increasing list of caspase substrates.
  JOURNAL   Cell Death Differ 5:997-1000 (1998)
REFERENCE   PMID:23070002
  AUTHORS   Safa AR
  TITLE     c-FLIP, a master anti-apoptotic regulator.
  JOURNAL   Exp Oncol 34:176-84 (2012)
REFERENCE   PMID:18304445
  AUTHORS   Jeong SY, Seol DW
  TITLE     The role of mitochondria in apoptosis.
  JOURNAL   BMB Rep 41:11-22 (2008)
REFERENCE   PMID:20533903
  AUTHORS   Parsons MJ, Green DR
  TITLE     Mitochondria in cell death.
  JOURNAL   Essays Biochem 47:99-114 (2010)
REFERENCE   PMID:15719025
  AUTHORS   Strasser A
  TITLE     The role of BH3-only proteins in the immune system.
  JOURNAL   Nat Rev Immunol 5:189-200 (2005)
REFERENCE   PMID:24278747
  AUTHORS   Schonthal AH
  TITLE     Endoplasmic reticulum stress: its role in disease and novel prospects for therapy.
  JOURNAL   Scientifica (Cairo) 2012:857516 (2012)
REFERENCE   PMID:21145844
  AUTHORS   Malhi H, Kaufman RJ
  TITLE     Endoplasmic reticulum stress in liver disease.
  JOURNAL   J Hepatol 54:795-809 (2011)
REFERENCE   PMID:18023214
  AUTHORS   Malhotra JD, Kaufman RJ
  TITLE     The endoplasmic reticulum and the unfolded protein response.
  JOURNAL   Semin Cell Dev Biol 18:716-31 (2007)
REFERENCE   PMID:16397578
  AUTHORS   Wu J, Kaufman RJ
  TITLE     From acute ER stress to physiological roles of the Unfolded Protein Response.
  JOURNAL   Cell Death Differ 13:374-84 (2006)
REFERENCE   PMID:21914490
  AUTHORS   Repnik U, Stoka V, Turk V, Turk B
  TITLE     Lysosomes and lysosomal cathepsins in cell death.
  JOURNAL   Biochim Biophys Acta 1824:22-33 (2012)
REFERENCE   PMID:22465226
  AUTHORS   Cesen MH, Pegan K, Spes A, Turk B
  TITLE     Lysosomal pathways to cell death and their therapeutic applications.
  JOURNAL   Exp Cell Res 318:1245-51 (2012)
REFERENCE   PMID:26231733
  AUTHORS   Dashzeveg N, Yoshida K
  TITLE     Cell death decision by p53 via control of the mitochondrial membrane.
  JOURNAL   Cancer Lett 367:108-12 (2015)
REFERENCE   PMID:22075987
  AUTHORS   Bouchier-Hayes L, Green DR
  TITLE     Caspase-2: the orphan caspase.
  JOURNAL   Cell Death Differ 19:51-7 (2012)
REFERENCE   PMID:18238895
  AUTHORS   Baptiste-Okoh N, Barsotti AM, Prives C
  TITLE     A role for caspase 2 and PIDD in the process of p53-mediated apoptosis.
  JOURNAL   Proc Natl Acad Sci U S A 105:1937-42 (2008)
REFERENCE   PMID:12949498
  AUTHORS   Aggarwal BB
  TITLE     Signalling pathways of the TNF superfamily: a double-edged sword.
  JOURNAL   Nat Rev Immunol 3:745-56 (2003)
REFERENCE   PMID:14737178
  AUTHORS   Steelman LS, Pohnert SC, Shelton JG, Franklin RA, Bertrand FE, McCubrey JA.
  TITLE     JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis.
  JOURNAL   Leukemia 18:189-218 (2004)
REFERENCE   PMID:9916983
  AUTHORS   Dragovich T, Rudin CM, Thompson CB
  TITLE     Signal transduction pathways that regulate cell survival and cell death.
  JOURNAL   Oncogene 17:3207-13 (1998)
REFERENCE   PMID:11520933
  AUTHORS   Sofroniew MV, Howe CL, Mobley WC
  TITLE     Nerve growth factor signaling, neuroprotection, and neural repair.
  JOURNAL   Annu Rev Neurosci 24:1217-81 (2001)
REFERENCE   PMID:24769728
  AUTHORS   Kristiansen M, Ham J
  TITLE     Programmed cell death during neuronal development: the sympathetic neuron model.
  JOURNAL   Cell Death Differ 21:1025-35 (2014)
REFERENCE   PMID:18208375
  AUTHORS   Logue SE, Martin SJ
  TITLE     Caspase activation cascades in apoptosis.
  JOURNAL   Biochem Soc Trans 36:1-9 (2008)
REFERENCE   PMID:19770840
  AUTHORS   Boivin WA, Cooper DM, Hiebert PR, Granville DJ
  TITLE     Intracellular versus extracellular granzyme B in immunity and disease: challenging the dogma.
  JOURNAL   Lab Invest 89:1195-220 (2009)
REFERENCE   PMID:20075940
  AUTHORS   Cullen SP, Brunet M, Martin SJ
  TITLE     Granzymes in cancer and immunity.
  JOURNAL   Cell Death Differ 17:616-23 (2010)
KO_PATHWAY  ko04210
///
